<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Heart failure,Articles with unsourced statements since July 2008,Articles needing additional references from December 2007,Articles with dead external links since June 2008,Heart failure,ABC (medicine),ACE inhibitor,ACE inhibitors,AV nodal reentrant tachycardia,Abdominojugular test,Accelerated idioventricular rhythm" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Heart_failure&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Heart_failure&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Heart failure - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Heart_failure";
		var wgTitle = "Heart failure";
		var wgAction = "view";
		var wgArticleId = "249930";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281740925;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Heart_failure skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Heart failure</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Heart failure</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:Heartfailure.jpg" class="image" title="Heartfailure.jpg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/99/Heartfailure.jpg/190px-Heartfailure.jpg" width="190" height="252" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>The major signs and symptoms of heart failure.</small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_I" title="ICD-10 Chapter I" class="mw-redirect">I</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gi30.htm+i50" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gi30.htm+i50" rel="nofollow">50.</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=428.0" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=428.0" rel="nofollow">428.0</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb16209.htm" class="external text" title="http://www.diseasesdatabase.com/ddb16209.htm" rel="nofollow">16209</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000158.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000158.htm" rel="nofollow">000158</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic3552.htm" class="external text" title="http://www.emedicine.com/med/topic3552.htm" rel="nofollow">med/3552</a>&#160; <a href="http://www.emedicine.com/emerg/topic108.htm#" class="external text" title="http://www.emedicine.com/emerg/topic108.htm#" rel="nofollow">emerg/108</a> <a href="http://www.emedicine.com/radio/topic189.htm#" class="external text" title="http://www.emedicine.com/radio/topic189.htm#" rel="nofollow">radio/189</a> <a href="http://www.emedicine.com/med/topic1367150.htm#" class="external text" title="http://www.emedicine.com/med/topic1367150.htm#" rel="nofollow">med/1367150</a> <a href="http://www.emedicine.com/ped/topic2636.htm#" class="external text" title="http://www.emedicine.com/ped/topic2636.htm#" rel="nofollow">ped/2636</a></td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D006333" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D006333" rel="nofollow">D006333</a></td>
</tr>
</table>
<p><b>Heart failure</b> (HF) is a condition in which a problem with the structure or function of the <a href="/wiki/Heart" title="Heart">heart</a> impairs its ability to supply sufficient <a href="/wiki/Blood_flow" title="Blood flow">blood flow</a> to meet the body's needs.<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup> It should not be confused with <a href="/wiki/Cardiac_arrest" title="Cardiac arrest">cardiac arrest</a> (see <a href="/wiki/Heart_failure#Terminology" title="Heart failure"><i>Terminology</i></a>, below).</p>
<p>Common causes of heart failure include <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> and other forms of <a href="/wiki/Ischemic_heart_disease" title="Ischemic heart disease" class="mw-redirect">ischemic heart disease</a>, <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, <a href="/wiki/Valvular_heart_disease" title="Valvular heart disease">valvular heart disease</a> and <a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">cardiomyopathy</a>.<sup id="cite_ref-Lancet2005_1-0" class="reference"><a href="#cite_note-Lancet2005-1" title=""><span>[</span>2<span>]</span></a></sup> Heart failure can cause a large variety of symptoms such as <a href="/wiki/Shortness_of_breath" title="Shortness of breath" class="mw-redirect">shortness of breath</a> (typically worse when lying flat, which is called <a href="/wiki/Orthopnea" title="Orthopnea">orthopnea</a>), <a href="/wiki/Coughing" title="Coughing" class="mw-redirect">coughing</a>, ankle swelling and reduced exercise capacity. Heart failure is often undiagnosed due to a lack of a universally agreed definition and challenges in definitive diagnosis. Treatment commonly consists of lifestyle measures (such as decreased salt intake) and medications, and sometimes devices or even surgery.</p>
<p>Heart failure is a common, costly, disabling and deadly condition.<sup id="cite_ref-Lancet2005_1-1" class="reference"><a href="#cite_note-Lancet2005-1" title=""><span>[</span>2<span>]</span></a></sup> In developing countries, around 2% of adults suffer from heart failure, but in those over the age of 65, this increases to 6—10%.<sup id="cite_ref-Lancet2005_1-2" class="reference"><a href="#cite_note-Lancet2005-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-pmid18799522_2-0" class="reference"><a href="#cite_note-pmid18799522-2" title=""><span>[</span>3<span>]</span></a></sup> Mostly due to costs of hospitalization, it is associated with a high health expenditure; costs have been estimated to amount to 2% of the total budget of the <a href="/wiki/National_Health_Service" title="National Health Service">National Health Service</a> in the United Kingdom, and more than $35 billion in the United States.<sup id="cite_ref-pmid12034163_3-0" class="reference"><a href="#cite_note-pmid12034163-3" title=""><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-pmid18086926_4-0" class="reference"><a href="#cite_note-pmid18086926-4" title=""><span>[</span>5<span>]</span></a></sup> Heart failure is associated with significantly reduced physical and mental health, resulting in a markedly decreased <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.<sup id="cite_ref-pmid11847161_5-0" class="reference"><a href="#cite_note-pmid11847161-5" title=""><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-pmid12445536_6-0" class="reference"><a href="#cite_note-pmid12445536-6" title=""><span>[</span>7<span>]</span></a></sup> With the exception of heart failure caused by reversible conditions, the condition usually worsens with time. Although some patients survive many years, progressive disease is associated with an overall annual mortality rate of 10%.<sup id="cite_ref-neubauer-2007_7-0" class="reference"><a href="#cite_note-neubauer-2007-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Terminology"><span class="tocnumber">1</span> <span class="toctext">Terminology</span></a></li>
<li class="toclevel-1"><a href="#Classification"><span class="tocnumber">2</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2"><a href="#Diagnostic_criteria"><span class="tocnumber">2.1</span> <span class="toctext">Diagnostic criteria</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">3</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2"><a href="#Symptoms"><span class="tocnumber">3.1</span> <span class="toctext">Symptoms</span></a>
<ul>
<li class="toclevel-3"><a href="#Left-sided_failure"><span class="tocnumber">3.1.1</span> <span class="toctext">Left-sided failure</span></a></li>
<li class="toclevel-3"><a href="#Right-sided_failure"><span class="tocnumber">3.1.2</span> <span class="toctext">Right-sided failure</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Signs"><span class="tocnumber">3.2</span> <span class="toctext">Signs</span></a>
<ul>
<li class="toclevel-3"><a href="#Left-sided_failure_2"><span class="tocnumber">3.2.1</span> <span class="toctext">Left-sided failure</span></a></li>
<li class="toclevel-3"><a href="#Right-sided_failure_2"><span class="tocnumber">3.2.2</span> <span class="toctext">Right-sided failure</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#Causes"><span class="tocnumber">4</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2"><a href="#Chronic_Heart_Failure"><span class="tocnumber">4.1</span> <span class="toctext">Chronic Heart Failure</span></a></li>
<li class="toclevel-2"><a href="#Acute_decompensated_heart_failure"><span class="tocnumber">4.2</span> <span class="toctext">Acute decompensated heart failure</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">5</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2"><a href="#Systolic_dysfunction"><span class="tocnumber">5.1</span> <span class="toctext">Systolic dysfunction</span></a></li>
<li class="toclevel-2"><a href="#Diastolic_dysfunction"><span class="tocnumber">5.2</span> <span class="toctext">Diastolic dysfunction</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">6</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Imaging"><span class="tocnumber">6.1</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2"><a href="#Electrophysiology"><span class="tocnumber">6.2</span> <span class="toctext">Electrophysiology</span></a></li>
<li class="toclevel-2"><a href="#Blood_tests"><span class="tocnumber">6.3</span> <span class="toctext">Blood tests</span></a></li>
<li class="toclevel-2"><a href="#Angiography"><span class="tocnumber">6.4</span> <span class="toctext">Angiography</span></a></li>
<li class="toclevel-2"><a href="#Monitoring"><span class="tocnumber">6.5</span> <span class="toctext">Monitoring</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">7</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Modalities"><span class="tocnumber">7.1</span> <span class="toctext">Modalities</span></a>
<ul>
<li class="toclevel-3"><a href="#Diet_and_lifestyle_measures"><span class="tocnumber">7.1.1</span> <span class="toctext">Diet and lifestyle measures</span></a></li>
<li class="toclevel-3"><a href="#Pharmacological_management"><span class="tocnumber">7.1.2</span> <span class="toctext">Pharmacological management</span></a>
<ul>
<li class="toclevel-4"><a href="#Angiotensin-modulating_agents"><span class="tocnumber">7.1.2.1</span> <span class="toctext">Angiotensin-modulating agents</span></a></li>
<li class="toclevel-4"><a href="#Diuretics"><span class="tocnumber">7.1.2.2</span> <span class="toctext">Diuretics</span></a></li>
<li class="toclevel-4"><a href="#Beta_blockers"><span class="tocnumber">7.1.2.3</span> <span class="toctext">Beta blockers</span></a></li>
<li class="toclevel-4"><a href="#Positive_inotropes"><span class="tocnumber">7.1.2.4</span> <span class="toctext">Positive inotropes</span></a></li>
<li class="toclevel-4"><a href="#Alternative_vasodilators"><span class="tocnumber">7.1.2.5</span> <span class="toctext">Alternative vasodilators</span></a></li>
<li class="toclevel-4"><a href="#Aldosterone_receptor_antagonists"><span class="tocnumber">7.1.2.6</span> <span class="toctext">Aldosterone receptor antagonists</span></a></li>
<li class="toclevel-4"><a href="#Recombinant_neuroendocrine_hormones"><span class="tocnumber">7.1.2.7</span> <span class="toctext">Recombinant neuroendocrine hormones</span></a></li>
<li class="toclevel-4"><a href="#Vasopressin_receptor_antagonists"><span class="tocnumber">7.1.2.8</span> <span class="toctext">Vasopressin receptor antagonists</span></a></li>
</ul>
</li>
<li class="toclevel-3"><a href="#Devices"><span class="tocnumber">7.1.3</span> <span class="toctext">Devices</span></a></li>
<li class="toclevel-3"><a href="#Surgery"><span class="tocnumber">7.1.4</span> <span class="toctext">Surgery</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Approach"><span class="tocnumber">7.2</span> <span class="toctext">Approach</span></a>
<ul>
<li class="toclevel-3"><a href="#Acute_decompensation"><span class="tocnumber">7.2.1</span> <span class="toctext">Acute decompensation</span></a></li>
<li class="toclevel-3"><a href="#Chronic_management"><span class="tocnumber">7.2.2</span> <span class="toctext">Chronic management</span></a></li>
<li class="toclevel-3"><a href="#Palliative_care_and_hospice"><span class="tocnumber">7.2.3</span> <span class="toctext">Palliative care and hospice</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">8</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">9</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Terminology" id="Terminology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=1" title="Edit section: Terminology">edit</a>]</span> <span class="mw-headline">Terminology</span></h2>
<p><b>Heart failure</b> is a global term for the physiological state in which cardiac output is insufficient for the body's needs.</p>
<p>This may occur when the cardiac output is low (often termed "congestive heart failure").<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p>In contrast, it may also occur when the body's requirements for oxygen and nutrients are increased, and demand outstrips what the heart can provide, (termed "high output cardiac failure") <sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup>. This can occur in the context of severe <a href="/wiki/Anemia" title="Anemia">anemia</a>, Gram negative <a href="/wiki/Septicaemia" title="Septicaemia" class="mw-redirect">septicaemia</a>, <a href="/wiki/Beriberi" title="Beriberi">beriberi</a> (vitamin B<sub>1</sub>/thiamine deficiency), <a href="/wiki/Thyrotoxicosis" title="Thyrotoxicosis" class="mw-redirect">thyrotoxicosis</a>, <a href="/wiki/Paget_disease" title="Paget disease" class="mw-redirect">Paget's disease</a>, <a href="/wiki/Arteriovenous_fistula" title="Arteriovenous fistula">arteriovenous fistulae</a> or <a href="/wiki/Arteriovenous_malformation" title="Arteriovenous malformation">arteriovenous malformations</a>.</p>
<p>Fluid overload is a common problem for people with heart failure, but is not synonymous with it. Patients with treated heart failure will often be euvolaemic (a term for normal fluid status), or more rarely, <a href="/wiki/Dehydration" title="Dehydration">dehydrated</a>.</p>
<p>Doctors use the words "acute" to mean of rapid onset, and "chronic" of long duration. Chronic heart failure is therefore a long term situation, usually with stable treated symptomatology.</p>
<p><a href="/wiki/Acute_decompensated_heart_failure" title="Acute decompensated heart failure">Acute decompensated heart failure</a>, which should just describe sudden onset HF, is also used to describe exacerbated or decompensated heart failure, referring to episodes in which a patient with known chronic heart failure abruptly develops symptoms.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>There are several terms which are closely related to heart failure, and may be the cause of heart failure, but should not be confused with it:</p>
<ul>
<li><a href="/wiki/Cardiac_arrest" title="Cardiac arrest">Cardiac arrest</a>, and <a href="/wiki/Asystole" title="Asystole">asystole</a> both refer to situations in which there is <i>no</i> cardiac output at all. Without urgent treatment, these result in sudden death.</li>
<li><a href="/wiki/Heart_attack" title="Heart attack" class="mw-redirect">Heart attack</a> refers to a blockage in a coronary (heart) artery resulting in heart muscle damage.</li>
<li><a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">Cardiomyopathy</a> refers specifically to problems within the heart muscle, and these problems usually result in heart failure. <b>Ischemic cardiomyopathy</b> implies that the cause of muscle damage is <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a>. <a href="/wiki/Dilated_cardiomyopathy" title="Dilated cardiomyopathy">Dilated cardiomyopathy</a> implies that the muscle damage has resulted in enlargement of the heart. <a href="/wiki/Hypertrophic_cardiomyopathy" title="Hypertrophic cardiomyopathy">Hypertrophic cardiomyopathy</a> involves enlargement and <i>thickening</i> of the heart muscle.</li>
</ul>
<p><a name="Classification" id="Classification"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=2" title="Edit section: Classification">edit</a>]</span> <span class="mw-headline">Classification</span></h2>
<p>There are many different ways to categorize heart failure, including:</p>
<ul>
<li>the side of the heart involved, (left heart failure versus right heart failure)</li>
<li>whether the abnormality is due to <a href="/wiki/Muscle_contraction" title="Muscle contraction">contraction</a> or relaxation of the heart (<a href="/wiki/Systolic_dysfunction" title="Systolic dysfunction" class="mw-redirect">systolic dysfunction</a> vs. <a href="/wiki/Diastolic_dysfunction" title="Diastolic dysfunction">diastolic dysfunction</a>)</li>
<li>whether the problem is primarily increased venous back pressure (behind) the heart, or failure to supply adequate arterial perfusion (in front of) the heart (backward vs. forward failure)</li>
<li>whether the abnormality is due to low cardiac output with high <a href="/wiki/Systemic_vascular_resistance" title="Systemic vascular resistance" class="mw-redirect">systemic vascular resistance</a> or high cardiac output with low vascular resistance (low-output heart failure vs. high-output heart failure)</li>
<li>the degree of functional impairment conferred by the abnormality (as in the NYHA functional classification)</li>
</ul>
<p><i>Functional</i> classification generally relies on the <a href="/wiki/New_York_Heart_Association_Functional_Classification" title="New York Heart Association Functional Classification">New York Heart Association Functional Classification</a>.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> The classes (I-IV) are:</p>
<ul>
<li>Class I: no limitation is experienced in any activities; there are no symptoms from ordinary activities.</li>
<li>Class II: slight, mild limitation of activity; the patient is comfortable at rest or with mild exertion.</li>
<li>Class III: marked limitation of any activity; the patient is comfortable only at rest.</li>
<li>Class IV: any physical activity brings on discomfort and symptoms occur at rest.</li>
</ul>
<p>This score documents severity of symptoms, and can be used to assess response to treatment. While its use is widespread, the NYHA score is not very reproducible and doesn't reliably predict the walking distance or exercise tolerance on formal testing.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p>In its 2001 guidelines, the <a href="/wiki/American_College_of_Cardiology" title="American College of Cardiology">American College of Cardiology</a>/<a href="/wiki/American_Heart_Association" title="American Heart Association">American Heart Association</a> working group introduced four stages of heart failure:<sup id="cite_ref-Hunt-2005_12-0" class="reference"><a href="#cite_note-Hunt-2005-12" title=""><span>[</span>13<span>]</span></a></sup></p>
<ul>
<li>Stage A: Patients at high risk for developing HF in the future but no functional or structural heart disorder;</li>
<li>Stage B: a structural heart disorder but no symptoms at any stage;</li>
<li>Stage C: previous or current symptoms of heart failure in the context of an underlying structural heart problem, but managed with medical treatment;</li>
<li>Stage D: advanced disease requiring hospital-based support, a heart transplant or palliative care.</li>
</ul>
<p>The ACC staging system is useful in that Stage A encompasses "pre-heart failure" - a stage where intervention with treatment can presumably prevent progression to overt symptoms. ACC stage A does not have a corresponding NYHA class. ACC Stage B would correspond to NYHA Class I. ACC Stage C corresponds to NYHA Class II and III, while ACC Stage D overlaps with NYHA Class IV.</p>
<p><a name="Diagnostic_criteria" id="Diagnostic_criteria"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=3" title="Edit section: Diagnostic criteria">edit</a>]</span> <span class="mw-headline">Diagnostic criteria</span></h3>
<p>No system of diagnostic criteria has been agreed as the <a href="/wiki/Gold_standard_(test)" title="Gold standard (test)">gold standard</a> for heart failure. Commonly used systems are the "<a href="/w/index.php?title=Framingham_criteria&amp;action=edit&amp;redlink=1" class="new" title="Framingham criteria (page does not exist)">Framingham criteria</a>"<sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup> (derived from the <a href="/wiki/Framingham_Heart_Study" title="Framingham Heart Study">Framingham Heart Study</a>), the "Boston criteria",<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> the "Duke criteria",<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup> and (in the setting of <a href="/wiki/Acute_myocardial_infarction" title="Acute myocardial infarction" class="mw-redirect">acute myocardial infarction</a>) the "<a href="/wiki/Killip_class" title="Killip class">Killip class</a>".<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=4" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p><a name="Symptoms" id="Symptoms"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=5" title="Edit section: Symptoms">edit</a>]</span> <span class="mw-headline">Symptoms</span></h3>
<p>Heart failure symptoms are traditionally and somewhat arbitrarily divided into "left" and "right" sided, recognizing that the left and right ventricles of the heart supply different portions of the circulation. However, heart failure is not exclusively <i>backward failure</i> (in the part of the circulation which drains to the ventricle).</p>
<p>There are several other exceptions to a simple left-right division of heart failure symptoms. Left sided <i>forward</i> failure overlaps with right sided <i>backward</i> failure. Additionally, the most common cause of right-sided heart failure is left-sided heart failure. The result is that patients commonly present with both sets of signs and symptoms.</p>
<p><a name="Left-sided_failure" id="Left-sided_failure"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=6" title="Edit section: Left-sided failure">edit</a>]</span> <span class="mw-headline">Left-sided failure</span></h4>
<p><i>Backward</i> failure of the left ventricle causes congestion of the pulmonary vasculature, and so the symptoms are predominantly respiratory in nature. The patient will have <a href="/wiki/Dyspnea" title="Dyspnea">dyspnea</a> (shortness of breath) on exertion (<i>dyspnée d'effort</i>) and in severe cases, dyspnea at rest. Increasing breathlessness on lying flat, called <a href="/wiki/Orthopnea" title="Orthopnea">orthopnea</a>, occurs. It is often measured in the number of pillows required to lie comfortably, and in severe cases, the patient may resort to sleeping while sitting up. Another symptom of heart failure is <a href="/wiki/Paroxysmal_nocturnal_dyspnea" title="Paroxysmal nocturnal dyspnea" class="mw-redirect">paroxysmal nocturnal dyspnea</a> also known as "cardiac asthma", a sudden nighttime attack of severe breathlessness, usually several hours after going to sleep. Easy fatigueability and exercise intolerance are also common complaints related to respiratory compromise.</p>
<p>Compromise of left ventricular <i>forward</i> function may result in symptoms of poor systemic circulation such as <a href="/wiki/Dizziness" title="Dizziness">dizziness</a>, <a href="/wiki/Confusion" title="Confusion" class="mw-redirect">confusion</a> and cool extremities at rest.</p>
<p><a name="Right-sided_failure" id="Right-sided_failure"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=7" title="Edit section: Right-sided failure">edit</a>]</span> <span class="mw-headline">Right-sided failure</span></h4>
<p><i>Backward</i> failure of the right ventricle leads to congestion of systemic capillaries. This helps to generate excess fluid accumulation in the body. This causes swelling under the skin (termed <a href="/wiki/Peripheral_edema" title="Peripheral edema">peripheral edema</a> or <a href="/wiki/Anasarca" title="Anasarca">anasarca</a>) and usually affects the dependent parts of the body first (causing foot and ankle swelling in people who are standing up, and sacral edema in people who are predominantly lying down). <a href="/wiki/Nocturia" title="Nocturia">Nocturia</a> (frequent nighttime urination) may occur when fluid from the legs is returned to the bloodstream while lying down at night. In progressively severe cases, <a href="/wiki/Ascites" title="Ascites">ascites</a> (fluid accumulation in the abdominal cavity causing swelling) and <a href="/wiki/Hepatomegaly" title="Hepatomegaly">hepatomegaly</a> (painful enlargement of the <a href="/wiki/Liver" title="Liver">liver</a>) may develop. Significant liver congestion may result in impaired liver function, and jaundice and even <a href="/wiki/Coagulopathy" title="Coagulopathy">coagulopathy</a> (problems of decreased blood clotting) may occur.</p>
<p><a name="Signs" id="Signs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=8" title="Edit section: Signs">edit</a>]</span> <span class="mw-headline">Signs</span></h3>
<p><a name="Left-sided_failure_2" id="Left-sided_failure_2"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=9" title="Edit section: Left-sided failure">edit</a>]</span> <span class="mw-headline">Left-sided failure</span></h4>
<p>Common respiratory signs are tachypnea (increased <i>rate</i> of breathing) and increased <i>work</i> of breathing (non-specific signs of respiratory distress). <a href="/wiki/Rales" title="Rales">Rales</a> or crackles, heard initially in the lung bases, and when severe, throughout the lung fields suggest the development of <a href="/wiki/Pulmonary_edema" title="Pulmonary edema">pulmonary edema</a> (fluid in the <a href="/wiki/Alveoli" title="Alveoli" class="mw-redirect">alveoli</a>). Dullness of the lung fields to finger percussion and reduced breath sounds at the bases of the lung may suggest the development of a <a href="/wiki/Pleural_effusion" title="Pleural effusion">pleural effusion</a> (fluid collection in between the lung and the chest wall). <a href="/wiki/Cyanosis" title="Cyanosis">Cyanosis</a> which suggests severe hypoxemia, is a late sign of extremely severe pulmonary edema.</p>
<p>Additional signs indicating left ventricular failure include a laterally displaced <a href="/wiki/Apex_beat" title="Apex beat">apex beat</a> (which occurs if the heart is enlarged) and a <a href="/wiki/Gallop_rhythm" title="Gallop rhythm">gallop rhythm</a> (additional heart sounds) may be heard as a marker of increased blood flow, or increased intra-cardiac pressure. <a href="/wiki/Heart_murmur" title="Heart murmur">Heart murmurs</a> may indicate the presence of valvular heart disease, either as a cause (e.g. <a href="/wiki/Aortic_stenosis" title="Aortic stenosis" class="mw-redirect">aortic stenosis</a>) or as a result (e.g. <a href="/wiki/Mitral_regurgitation" title="Mitral regurgitation">mitral regurgitation</a>) of the heart failure.</p>
<p><a name="Right-sided_failure_2" id="Right-sided_failure_2"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=10" title="Edit section: Right-sided failure">edit</a>]</span> <span class="mw-headline">Right-sided failure</span></h4>
<p>Physical examination can reveal pitting peripheral <a href="/wiki/Edema" title="Edema">edema</a>, ascites, and hepatomegaly. <a href="/wiki/Jugular_venous_pressure" title="Jugular venous pressure">Jugular venous pressure</a> is frequently assessed as a marker of fluid status, which can be accentuated by the <a href="/wiki/Abdominojugular_test" title="Abdominojugular test">hepatojugular reflux</a>. If the right ventriclar pressure is increased, a <a href="/w/index.php?title=Parasternal_heave&amp;action=edit&amp;redlink=1" class="new" title="Parasternal heave (page does not exist)">parasternal heave</a> may be present, signifying the compensatory increase in contraction strength.</p>
<p><a name="Causes" id="Causes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=11" title="Edit section: Causes">edit</a>]</span> <span class="mw-headline">Causes</span></h2>
<p><a name="Chronic_Heart_Failure" id="Chronic_Heart_Failure"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=12" title="Edit section: Chronic Heart Failure">edit</a>]</span> <span class="mw-headline">Chronic Heart Failure</span></h3>
<p>The predominance of causes of heart failure are difficult to analyse due to challenges in diagnosis, differences in populations, and changing prevalence of causes with age.</p>
<p>A 19 year study of 13000 healthy adults in the United States (the <a href="/wiki/National_Health_and_Nutrition_Examination_Survey" title="National Health and Nutrition Examination Survey">National Health and Nutrition Examination Survey</a> (NHANES I) found the following causes ranked by Population Attributable Risk score: <sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<ol>
<li><a href="/wiki/Ischaemic_Heart_Disease" title="Ischaemic Heart Disease" class="mw-redirect">Ischaemic Heart Disease</a> 62%</li>
<li>Cigarette Smoking 16%</li>
<li><a href="/wiki/Hypertension" title="Hypertension">Hypertension</a> (high blood pressure)10%</li>
<li><a href="/wiki/Obesity" title="Obesity">Obesity</a> 8%</li>
<li><a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">Diabetes</a> 3%</li>
<li>Valvular Heart Disease 2% (much higher in older populations)</li>
</ol>
<p>An Italian registry of over 6200 patients with heart failure showed the following underlying causes: <sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<ol>
<li>Ischaemic Heart Disease 40%</li>
<li>Dilated Cardiomyopathy 32%</li>
<li>Valvular Heart Disease 12%</li>
<li>Hypertension 11%</li>
<li>Other 5%</li>
</ol>
<p>Rarer causes of heart failure include:</p>
<ul>
<li>Viral <a href="/wiki/Myocarditis" title="Myocarditis">Myocarditis</a> (an infection of the heart muscle)</li>
<li>Infiltrations of the muscle such as <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a></li>
<li>HIV cardiomyopathy (caused by <a href="/wiki/Human_Immunodeficiency_Virus" title="Human Immunodeficiency Virus" class="mw-redirect">Human Immunodeficiency Virus</a>)</li>
<li>Connective Tissue Diseases such as <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a></li>
<li>Abuse of drugs such as alcohol</li>
<li>Pharmaceutical drugs such as chemotherapeutic agents.</li>
<li>Arrhythmias</li>
</ul>
<p><a href="/wiki/Obstructive_Sleep_Apnea" title="Obstructive Sleep Apnea" class="mw-redirect">Obstructive Sleep Apnea</a> a condition of sleep disordered breathing overlaps with obesity, hypertension and diabetes and is regarded as an independent cause of heart failure.</p>
<p><a name="Acute_decompensated_heart_failure" id="Acute_decompensated_heart_failure"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=13" title="Edit section: Acute decompensated heart failure">edit</a>]</span> <span class="mw-headline">Acute decompensated heart failure</span></h3>
<dl>
<dd><i>See main article: <a href="/wiki/Acute_decompensated_heart_failure" title="Acute decompensated heart failure">Acute decompensated heart failure</a></i><br /></dd>
</dl>
<p>Chronic stable heart failure may easily <a href="/wiki/Decompensation" title="Decompensation">decompensate</a>. This most commonly results from an intercurrent illness (such as <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>), <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (a heart attack), <a href="/wiki/Cardiac_arrhythmia" title="Cardiac arrhythmia">arrhythmias</a>, uncontrolled <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, or a patient's failure to maintain a fluid restriction, diet or medication.<sup id="cite_ref-OPTIMIZE-HF_19-0" class="reference"><a href="#cite_note-OPTIMIZE-HF-19" title=""><span>[</span>20<span>]</span></a></sup> Other well recognised precipitating factors include <a href="/wiki/Anaemia" title="Anaemia" class="mw-redirect">anaemia</a> and <a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">hyperthyroidism</a> which place additional strain on the heart muscle. Excessive fluid or salt intake, and medication that causes fluid retention such as <a href="/wiki/Non-steroidal_anti-inflammatory_drug" title="Non-steroidal anti-inflammatory drug">NSAIDs</a> and <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>, may also precipitate decompensation.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=14" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Question_book-new.svg" class="image" title="Question book-new.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This section <b>does not <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">cite</a> any <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">references or sources</a></b>. Please help <a href="http://en.wikipedia.org/w/index.php?title=Heart_failure&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Heart_failure&amp;action=edit" rel="nofollow">improve this article</a> by adding citations to <a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources">reliable sources</a> (ideally, using <i><a href="/wiki/Wikipedia:Footnotes" title="Wikipedia:Footnotes">inline citations</a></i>). Unsourced material may be <a href="/wiki/Template:Fact" title="Template:Fact">challenged</a> and <a href="/wiki/Wikipedia:BURDEN" title="Wikipedia:BURDEN" class="mw-redirect">removed</a>. <small><i>(December 2007)</i></small></td>
</tr>
</table>
<p>Heart failure is caused by any condition which reduces the efficiency of the myocardium, or heart muscle, through damage or overloading. As such, it can be caused by as diverse an array of conditions as myocardial infarction (in which the heart muscle is starved of oxygen and dies), hypertension (which increases the force of contraction needed to pump blood) and <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a> (in which protein is deposited in the heart muscle, causing it to stiffen). Over time these increases in workload will produce changes to the heart itself:</p>
<ul>
<li>Reduced contractility, or force of contraction, due to overloading of the <a href="/wiki/Ventricle" title="Ventricle">ventricle</a>. In health, increased filling of the ventricle results in increased contractility (by the <a href="/wiki/Frank-Starling_law_of_the_heart" title="Frank-Starling law of the heart">Frank-Starling law of the heart</a>) and thus a rise in cardiac output. In heart failure this mechanism fails, as the ventricle is loaded with blood to the point where heart muscle contraction becomes less efficient. This is due to reduced ability to cross-link <a href="/wiki/Actin" title="Actin">actin</a> and <a href="/wiki/Myosin" title="Myosin">myosin</a> filaments in over-stretched heart muscle.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup></li>
<li>A reduced stroke volume, as a result of a failure of <a href="/wiki/Systole_(medicine)" title="Systole (medicine)">systole</a>, <a href="/wiki/Diastole" title="Diastole">diastole</a> or both. Increased <a href="/wiki/End_systolic_volume" title="End systolic volume" class="mw-redirect">end systolic volume</a> is usually caused by reduced contractility. Decreased <a href="/wiki/End_diastolic_volume" title="End diastolic volume" class="mw-redirect">end diastolic volume</a> results from impaired ventricular filling – as occurs when the compliance of the ventricle falls (i.e. when the walls stiffen).</li>
<li>Reduced spare capacity. As the heart works harder to meet normal metabolic demands, the amount cardiac output can increase in times of increased oxygen demand (e.g. exercise) is reduced. This contributes to the exercise intolerance commonly seen in heart failure. This translates to the loss of one's cardiac reserve. The cardiac reserve refers to the ability of the heart to work harder during exercise or strenuous activity. Since the heart has to work harder to meet the normal metabolic demands, it is incapable of meeting the metabolic demands of the body during exercise.</li>
<li>Increased heart rate, stimulated by increased sympathetic activity in order to maintain cardiac output. Initially, this helps compensate for heart failure by maintaining blood pressure and perfusion, but places further strain on the myocardium, increasing coronary perfusion requirements, which can lead to worsening of ischemic heart disease. Sympathetic activity may also cause potentially fatal <a href="/wiki/Arrhythmias" title="Arrhythmias" class="mw-redirect">arrhythmias</a>.</li>
<li><a href="/wiki/Hypertrophy" title="Hypertrophy">Hypertrophy</a> (an increase in physical size) of the myocardium, caused by the terminally differentiated heart muscle fibres increasing in size in an attempt to improve contractility. This may contribute to the increased stiffness and decreased ability to relax during diastole.</li>
<li>Enlargement of the ventricles, contributing to the enlargement and spherical shape of the failing heart. The increase in ventricular volume also causes a reduction in stroke volume due to mechanical and contractile inefficiency.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup></li>
</ul>
<p>The general effect is one of reduced cardiac output and increased strain on the heart. This increases the risk of cardiac arrest (specifically due to ventricular dysrhythmias), and reduces blood supply to the rest of the body. In chronic disease the reduced cardiac output causes a number of changes in the rest of the body, some of which are physiological compensations, some of which are part of the disease process:</p>
<ul>
<li>Arterial blood pressure falls. This destimulates <a href="/wiki/Baroreceptors" title="Baroreceptors" class="mw-redirect">baroreceptors</a> in the <a href="/wiki/Carotid_body" title="Carotid body">carotid body</a> and <a href="/wiki/Aortic_arch" title="Aortic arch">aortic arch</a> which link to the nucleus tractus solitarius. This center in the brain increases sympathetic activity, releasing catecholamines into the blood stream. Binding to alpha-1 receptors results in systemic arterial <a href="/wiki/Vasoconstriction" title="Vasoconstriction">vasoconstriction</a>. This helps restore blood pressure but also increases the total peripheral resistance, increasing the workload of the heart. Binding to beta-1 receptors in the myocardium increases the heart rate and make contractions more forceful, in an attempt to increase cardiac output. This also, however, increases the amount of work the heart has to perform.</li>
<li>Increased sympathetic stimulation also causes the <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamus</a> to secrete <a href="/wiki/Vasopressin" title="Vasopressin">vasopressin</a> (also known as antidiuretic hormone or ADH), which causes fluid retention at the kidneys. This increases the blood volume and blood pressure.</li>
<li>Reduced <a href="/wiki/Perfusion" title="Perfusion">perfusion</a> (blood flow) to the kidneys stimulates the release of <a href="/wiki/Renin" title="Renin">renin</a> – an enzyme which catalyses the production of the potent vasopressor <a href="/wiki/Angiotensin" title="Angiotensin">angiotensin</a>. Angiotensin and its metabolites cause further vasocontriction, and stimulate increased secretion of the steroid <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a> from the <a href="/wiki/Adrenal_glands" title="Adrenal glands" class="mw-redirect">adrenal glands</a>. This promotes salt and fluid retention at the kidneys, also increasing the blood volume.</li>
<li>The chronically high levels of circulating neuroendocrine hormones such as <a href="/wiki/Catecholamines" title="Catecholamines" class="mw-redirect">catecholamines</a>, renin, angiotensin, and aldosterone affects the myocardium directly, causing structural remodelling of the heart over the long term. Many of these remodelling effects seem to be mediated by transforming growth factor beta (TGF-beta), which is a common downstream target of the signal transduction cascade initiated by catecholamines<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup> and angiotensin II<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup>, and also by epidermal growth factor (EGF), which is a target of the signaling pathway activated by aldosterone<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup></li>
<li>Reduced perfusion of skeletal muscle causes atrophy of the muscle fibres. This can result in weakness, increased fatigueability and decreased peak strength - all contributing to exercise intolerance.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup></li>
</ul>
<p>The increased peripheral resistance and greater blood volume place further strain on the heart and accelerates the process of damage to the myocardium. Vasoconstriction and fluid retention produce an increased hydrostatic pressure in the capillaries. This shifts of the balance of forces in favour of <a href="/wiki/Interstitial_fluid" title="Interstitial fluid">interstitial fluid</a> formation as the increased pressure forces additional fluid out of the blood, into the tissue. This results in <a href="/wiki/Edema" title="Edema">edema</a> (fluid build-up) in the tissues. In right-sided heart failure this commonly starts in the ankles where venous pressure is high due to the effects of gravity (although if the patient is bed-ridden, fluid accumulation may begin in the sacral region.) It may also occur in the abdominal cavity, where the fluid build-up is called ascites. In left-sided heart failure <a href="/wiki/Edema" title="Edema">edema</a> can occur in the lungs - this is called cardiogenic <a href="/wiki/Pulmonary_oedema" title="Pulmonary oedema" class="mw-redirect">pulmonary oedema</a>. This reduces spare capacity for ventilation, causes stiffening of the lungs and reduces the efficiency of gas exchange by increasing the distance between the air and the blood. The consequences of this are shortness of breath, <a href="/wiki/Orthopnoea" title="Orthopnoea" class="mw-redirect">orthopnoea</a> and <a href="/wiki/Paroxysmal_nocturnal_dyspnea" title="Paroxysmal nocturnal dyspnea" class="mw-redirect">paroxysmal nocturnal dyspnea</a>.</p>
<p>The symptoms of heart failure are largely determined by which side of the heart fails. The left side pumps blood into the systemic circulation, whilst the right side pumps blood into the <a href="/wiki/Pulmonary_circulation" title="Pulmonary circulation">pulmonary circulation</a>. Whilst left-sided heart failure will reduce cardiac output to the systemic circulation, the initial symptoms often manifest due to effects on the pulmonary circulation. In systolic dysfunction, the ejection fraction is decreased, leaving an abnormally elevated volume of blood in the left ventricle. In diastolic dysfunction, end-diastolic ventricular pressure will be high. This increase in volume or pressure backs up to the left atrium and then to the pulmonary veins. Increased volume or pressure in the pulmonary veins impairs the normal drainage of the alveoli and favors the flow of fluid from the capillaries to the lung parenchyma, causing pulmonary edema. This impairs gas exchange. Thus, left-sided heart failure often presents with respiratory symptoms: shortness of breath, orthopnea and paroxysmal nocturnal dyspnea.</p>
<p>In severe cardiomyopathy, the effects of decreased cardiac output and poor perfusion become more apparent, and patients will manifest with cold and clammy extremities, cyanosis, claudication, generalized weakness, dizziness, and <a href="/wiki/Syncope" title="Syncope">syncope</a></p>
<p>The resultant hypoxia caused by pulmonary edema causes vasoconstriction in the pulmonary circulation, which results in pulmonary hypertension. Since the right ventricle generates far lower pressures than the left ventricle (approximately 20 mmHg versus around 120 mmHg, respectively, in the healthy individual) but nonetheless generates cardiac output exactly equal to the left ventricle, this means that a small increase in pulmonary vascular resistance causes a large increase in amount of work the right ventricle must perform. However, the main mechanism by which left-sided heart failure causes right-sided heart failure is actually not well understood. Some theories invoke mechanisms that are mediated by neurohormonal activation. Mechanical effects may also contribute. As the left ventricle distends, the intraventricular septum bows into the right ventricle, decreasing the capacity of the right ventricle.</p>
<p><a name="Systolic_dysfunction" id="Systolic_dysfunction"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=15" title="Edit section: Systolic dysfunction">edit</a>]</span> <span class="mw-headline">Systolic dysfunction</span></h3>
<p>Heart failure caused by systolic dysfunction is more readily recognized. It can be simplistically described as failure of the pump function of the heart. It is characterized by a decreased ejection fraction (less than 45%). The strength of ventricular contraction is attenuated and inadequate for creating an adequate stroke volume, resulting in inadequate cardiac output. In general, this is caused by dysfunction or destruction of cardiac myocytes or their molecular components. In congenital diseases such as <a href="/wiki/Duchenne_muscular_dystrophy" title="Duchenne muscular dystrophy">Duchenne muscular dystrophy</a>, the molecular structure of individual myocytes is affected. Myocytes and their components can be damaged by inflammation (such as in <a href="/wiki/Myocarditis" title="Myocarditis">myocarditis</a>) or by infiltration (such as in amyloidosis). Toxins and pharmacological agents (such as <a href="/wiki/Ethanol" title="Ethanol">ethanol</a>, <a href="/wiki/Cocaine" title="Cocaine">cocaine</a>, and <a href="/wiki/Amphetamines" title="Amphetamines" class="mw-redirect">amphetamines</a>) cause intracellular damage and oxidative stress. The most common mechanism of damage is ischemia causing infarction and scar formation. After myocardial infarction, dead myocytes are replaced by scar tissue, deleteriously affecting the function of the myocardium. On echocardiogram, this is manifest by abnormal or absent wall motion.</p>
<p>Because the ventricle is inadequately emptied, ventricular end-diastolic pressure and volumes increase. This is transmitted to the atrium. On the left side of the heart, the increased pressure is transmitted to the pulmonary vasculature, and the resultant hydrostatic pressure favors extravassation of fluid into the lung parenchyma, causing pulmonary edema. On the right side of the heart, the increased pressure is transmitted to the systemic venous circulation and systemic capillary beds, favoring extravassation of fluid into the tissues of target organs and extremities, resulting in <a href="/w/index.php?title=Dependent_peripheral_edema&amp;action=edit&amp;redlink=1" class="new" title="Dependent peripheral edema (page does not exist)">dependent peripheral edema</a>.</p>
<p><a name="Diastolic_dysfunction" id="Diastolic_dysfunction"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=16" title="Edit section: Diastolic dysfunction">edit</a>]</span> <span class="mw-headline">Diastolic dysfunction</span></h3>
<p>Heart failure caused by diastolic dysfunction is generally described as the failure of the ventricle to adequately relax and typically denotes a stiffer ventricular wall. This causes inadequate filling of the ventricle, and therefore results in an inadequate stroke volume. The failure of ventricular relaxation also results in elevated end-diastolic pressures, and the end result is identical to the case of systolic dysfunction (pulmonary edema in left heart failure, peripheral edema in right heart failure.)</p>
<p>Diastolic dysfunction can be caused by processes similar to those that cause systolic dysfunction, particularly causes that affect cardiac remodeling.</p>
<p>Diastolic dysfunction may not manifest itself except in physiologic extremes if systolic function is preserved. The patient may be completely asymptomatic at rest. However, they are exquisitely sensitive to increases in heart rate, and sudden bouts of tachycardia (which can be caused simply by physiological responses to exertion, fever, or dehydration, or by pathological tachyarrhythmias such as <a href="/wiki/Atrial_fibrillation_with_rapid_ventricular_response" title="Atrial fibrillation with rapid ventricular response">atrial fibrillation with rapid ventricular response</a>) may result in <a href="/wiki/Flash_pulmonary_edema" title="Flash pulmonary edema">flash pulmonary edema</a>. Adequate rate control (usually with a pharmacological agent that slows down AV conduction such as a calcium channel blocker or a beta-blocker) is therefore key to preventing decompensation.</p>
<p>Left ventricular diastolic function can be determined through echocardiography by measurement of various parameters such as the E/A ratio (early-to-atrial left ventricular filling ratio), the E (early left ventricular filling) deceleration time, and the isovolumic relaxation time.</p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=17" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Congestive_heart_failure_x-ray.png" class="image" title="Chest x-ray showing an enlarged cardiac silhouette due to congestive heart failure."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/49/Congestive_heart_failure_x-ray.png/180px-Congestive_heart_failure_x-ray.png" width="180" height="231" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Congestive_heart_failure_x-ray.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Chest x-ray showing an enlarged cardiac silhouette due to congestive heart failure.</div>
</div>
</div>
<p><a name="Imaging" id="Imaging"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=18" title="Edit section: Imaging">edit</a>]</span> <span class="mw-headline">Imaging</span></h3>
<p><a href="/wiki/Echocardiography" title="Echocardiography">Echocardiography</a> is commonly used to support a clinical diagnosis of heart failure. This modality uses <a href="/wiki/Ultrasound" title="Ultrasound">ultrasound</a> to determine the <a href="/wiki/Stroke_volume" title="Stroke volume">stroke volume</a> (SV, the amount of blood in the heart that exits the ventricles with each beat), the <a href="/wiki/End-diastolic_volume" title="End-diastolic volume">end-diastolic volume</a> (EDV, the total amount of blood at the end of diastole), and the SV in proportion to the EDV, a value known as the <i><a href="/wiki/Ejection_fraction" title="Ejection fraction">ejection fraction</a></i>. In pediatrics, the <a href="/w/index.php?title=Shortening_fraction&amp;action=edit&amp;redlink=1" class="new" title="Shortening fraction (page does not exist)">shortening fraction</a> is the preferred measure of systolic function. Normally, the EF should be between 50% and 70%; in systolic heart failure, it drops below 40%. Echocardiography can also identify valvular heart disease and assess the state of the <a href="/wiki/Pericardium" title="Pericardium">pericardium</a> (the connective tissue sac surrounding the heart). Echocardiography may also aid in deciding what treatments will help the patient, such as medication, insertion of an <a href="/wiki/Implantable_cardioverter-defibrillator" title="Implantable cardioverter-defibrillator">implantable cardioverter-defibrillator</a> or <a href="/wiki/Cardiac_resynchronization_therapy" title="Cardiac resynchronization therapy" class="mw-redirect">cardiac resynchronization therapy</a>. Echocardiography can also help determine if acute myocardial ischemia is the precipitating cause, and may manifest as regional wall motion abnormalities on echo.</p>
<p><a href="/wiki/Chest_X-ray" title="Chest X-ray" class="mw-redirect">Chest X-rays</a> are frequently used to aid in the diagnosis of CHF. In the compensated patient, this may show <a href="/wiki/Cardiomegaly" title="Cardiomegaly">cardiomegaly</a> (visible enlargement of the heart), quantified as the <i>cardiothoracic ratio</i> (proportion of the heart size to the chest). In left ventricular failure, there may be evidence of vascular redistribution ("upper lobe blood diversion" or "cephalization"), <a href="/wiki/Kerley_lines" title="Kerley lines">Kerley lines</a>, cuffing of the areas around the <a href="/wiki/Bronchi" title="Bronchi" class="mw-redirect">bronchi</a>, and interstitial edema.</p>
<p><a name="Electrophysiology" id="Electrophysiology"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=19" title="Edit section: Electrophysiology">edit</a>]</span> <span class="mw-headline">Electrophysiology</span></h3>
<p>An <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">electrocardiogram</a> (ECG/EKG) is used to identify arrhythmias, <a href="/wiki/Ischemic_heart_disease" title="Ischemic heart disease" class="mw-redirect">ischemic heart disease</a>, <a href="/wiki/Right_ventricular_hypertrophy" title="Right ventricular hypertrophy">right</a> and <a href="/wiki/Left_ventricular_hypertrophy" title="Left ventricular hypertrophy">left ventricular hypertrophy</a>, and presence of conduction delay or abnormalities (e.g. <a href="/wiki/Left_bundle_branch_block" title="Left bundle branch block">left bundle branch block</a>). An ECG may also diagnose acute myocardial ischemia or infarction (if ST depression or elevation are present).</p>
<p><a name="Blood_tests" id="Blood_tests"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=20" title="Edit section: Blood tests">edit</a>]</span> <span class="mw-headline">Blood tests</span></h3>
<p><a href="/wiki/Blood_test" title="Blood test">Blood tests</a> routinely performed include <a href="/wiki/Electrolyte" title="Electrolyte">electrolytes</a> (<a href="/wiki/Sodium" title="Sodium">sodium</a>, <a href="/wiki/Potassium" title="Potassium">potassium</a>), measures of <a href="/wiki/Renal_function" title="Renal function">renal function</a>, <a href="/wiki/Liver_function_tests" title="Liver function tests">liver function tests</a>, <a href="/wiki/Thyroid_function_test" title="Thyroid function test" class="mw-redirect">thyroid function tests</a>, a <a href="/wiki/Complete_blood_count" title="Complete blood count">complete blood count</a>, and often <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a> if infection is suspected. An elevated <a href="/wiki/Brain_natriuretic_peptide" title="Brain natriuretic peptide">B-type natriuretic peptide</a> (BNP) is a specific test indicative of heart failure. Additionally, BNP can be used to differentiate between causes of dyspnea due to heart failure from other causes of dyspnea. If myocardial infarction is suspected, various <a href="/wiki/Cardiac_marker" title="Cardiac marker">cardiac markers</a> may be used.</p>
<p>According to a <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> comparing BNP and N-terminal pro-BNP (NTproBNP) in the diagnosis of heart failure, BNP is a better indicator for heart failure and left ventricular systolic dysfunction. In groups of symptomatic patients, a diagnostic <a href="/wiki/Odds_ratio" title="Odds ratio">odds ratio</a> of 27 for BNP compares with a <a href="/wiki/Sensitivity" title="Sensitivity">sensitivity</a> of 85% and <a href="/wiki/Specificity" title="Specificity">specificity</a> of 84% in detecting heart failure. <sup id="cite_ref-pmid18290826_27-0" class="reference"><a href="#cite_note-pmid18290826-27" title=""><span>[</span>28<span>]</span></a></sup></p>
<p><a name="Angiography" id="Angiography"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=21" title="Edit section: Angiography">edit</a>]</span> <span class="mw-headline">Angiography</span></h3>
<p>Heart failure may be the result of coronary artery disease, and its prognosis depends in part on the ability of the <a href="/wiki/Coronary_artery" title="Coronary artery" class="mw-redirect">coronary arteries</a> to supply blood to the <a href="/wiki/Myocardium" title="Myocardium" class="mw-redirect">myocardium</a> (heart muscle). As a result, <a href="/wiki/Coronary_catheterization" title="Coronary catheterization">coronary catheterization</a> may be used to identify possibilities for revascularisation through <a href="/wiki/Percutaneous_coronary_intervention" title="Percutaneous coronary intervention">percutaneous coronary intervention</a> or <a href="/wiki/Coronary_artery_bypass_surgery" title="Coronary artery bypass surgery">bypass surgery</a>.</p>
<p><a name="Monitoring" id="Monitoring"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=22" title="Edit section: Monitoring">edit</a>]</span> <span class="mw-headline">Monitoring</span></h3>
<p>Various measures are often used to assess the progress of patients being treated for heart failure. These include <a href="/wiki/Fluid_balance" title="Fluid balance">fluid balance</a> (calculation of fluid intake and excretion), monitoring <a href="/wiki/Body_weight" title="Body weight">body weight</a> (which in the shorter term reflects fluid shifts).</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=23" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<table class="metadata plainlinks ambox ambox-move" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Splitsection.svg" class="image" title="Splitsection.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Splitsection.svg/40px-Splitsection.svg.png" width="40" height="20" border="0" /></a></div>
</td>
<td class="mbox-text" style="">It has been suggested that this section be <a href="/wiki/Wikipedia:Splitting" title="Wikipedia:Splitting">split</a> into a new article. (<a href="/wiki/Talk:Heart_failure" title="Talk:Heart failure">Discuss</a>)</td>
</tr>
</table>
<p>Treatment focuses on improving the symptoms and preventing the progression of the disease. Reversible causes of the heart failure also need to be addressed: (e.g. <a href="/wiki/Infection" title="Infection">infection</a>, <a href="/wiki/Alcohol" title="Alcohol">alcohol</a> ingestion, anemia, <a href="/wiki/Thyrotoxicosis" title="Thyrotoxicosis" class="mw-redirect">thyrotoxicosis</a>, <a href="/wiki/Arrhythmia" title="Arrhythmia" class="mw-redirect">arrhythmia</a>, hypertension). Treatments include lifestyle and pharmacological modalities.</p>
<p><a name="Modalities" id="Modalities"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=24" title="Edit section: Modalities">edit</a>]</span> <span class="mw-headline">Modalities</span></h3>
<p><a name="Diet_and_lifestyle_measures" id="Diet_and_lifestyle_measures"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=25" title="Edit section: Diet and lifestyle measures">edit</a>]</span> <span class="mw-headline">Diet and lifestyle measures</span></h4>
<p>Patients with CHF are educated to undertake various non-<a href="/wiki/Pharmacological" title="Pharmacological" class="mw-redirect">pharmacological</a> measures to improve symptoms and prognosis. Such measures include:<sup id="cite_ref-Smith_28-0" class="reference"><a href="#cite_note-Smith-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<ul>
<li>Moderate physical activity, when symptoms are mild or moderate; or <a href="/wiki/Bed_rest" title="Bed rest">bed rest</a> when symptoms are severe.</li>
<li>If <a href="/wiki/Sleep_apnea" title="Sleep apnea">sleep apnea</a> is identified, treat with CPAP, BiPAP, dental appliances or surgery. Sleep apnea is an under recognized risk factor for heart failure</li>
<li>Weight reduction – through physical activity and dietary modification, as <a href="/wiki/Obesity" title="Obesity">obesity</a> is a risk factor for heart failure and left ventricular hypertrophy.</li>
<li>Monitor weight - this is a parameter that can easily be measured at home. Rapid weight increase is generally due to fluid retention. Weight gain of more than 2 pounds is associated with admission to the hospital for heart failure<sup id="cite_ref-pmidpending_29-0" class="reference"><a href="#cite_note-pmidpending-29" title=""><span>[</span>30<span>]</span></a></sup></li>
<li>Sodium restriction – excessive sodium intake may precipitate or exacerbate heart failure, thus a "no added salt" diet (60–100 <a href="/wiki/Mmol" title="Mmol" class="mw-redirect">mmol</a> total daily intake) is recommended for patients with CHF. More severe restrictions may be required in severe CHF.</li>
<li>Fluid restriction – patients with CHF have a diminished ability to <a href="/wiki/Excrete" title="Excrete" class="mw-redirect">excrete</a> <a href="/wiki/Free_water" title="Free water" class="mw-redirect">free water</a> load. Hyponatremia frequently develops in decompensated heart failure due to the effects of excess circulating neuroendocrine hormones. While the activation of the renin-angiotensin-aldosterone axis due to decreased renal perfusion promotes both sodium and water retention, the activation of atrial natriuretic peptide due to atrial stretch favors sodium excretion, and the activation of antidiuretic hormone due to peripheral baroreceptors that sense hypotension as well as due to the activation of the sympathetic nervous system favors water retention alone, leading to disproportionately more water retention than sodium retention. The severity of the hyponatremia during an episode of decompensated heart failure can be predictive of mortality. Generally water intake should be limited to 1.5 L daily or less in patients with <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremia</a>, though fluid restriction may be beneficial regardless in symptomatic reduction.</li>
</ul>
<p><a name="Pharmacological_management" id="Pharmacological_management"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=26" title="Edit section: Pharmacological management">edit</a>]</span> <span class="mw-headline">Pharmacological management</span></h4>
<p>There is a significant evidence–practice gap in the treatment of CHF; particularly the underuse of <a href="/wiki/ACE_inhibitors" title="ACE inhibitors" class="mw-redirect">ACE inhibitors</a> and <a href="/wiki/Beta-blocker" title="Beta-blocker" class="mw-redirect">β-blockers</a> and aldosterone antagonists which have been shown to provide mortality benefit.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup> Treatment of CHF aims to relieve symptoms, to maintain a <a href="/wiki/Euvolemia" title="Euvolemia" class="mw-redirect">euvolemic</a> state (normal fluid level in the circulatory system), and to improve <a href="/wiki/Prognosis" title="Prognosis">prognosis</a> by delaying progression of heart failure and reducing cardiovascular risk. Drugs used include: <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> agents, <a href="/wiki/Vasodilator" title="Vasodilator" class="mw-redirect">vasodilator</a> agents, positive <a href="/wiki/Inotrope" title="Inotrope">inotropes</a>, <a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE inhibitors</a>, <a href="/wiki/Beta_blocker" title="Beta blocker">beta blockers</a>, and <a href="/wiki/Aldosterone_antagonist" title="Aldosterone antagonist">aldosterone antagonists</a> (e.g. <a href="/wiki/Spironolactone" title="Spironolactone">spironolactone</a>). Some drugs which increase heart function, such as the positive inotrope <a href="/wiki/Milrinone" title="Milrinone">Milrinone</a>, lead to increased mortality, and are contraindicated.<sup id="cite_ref-Packer-1989_31-0" class="reference"><a href="#cite_note-Packer-1989-31" title=""><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-Packer-1991_32-0" class="reference"><a href="#cite_note-Packer-1991-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p><a name="Angiotensin-modulating_agents" id="Angiotensin-modulating_agents"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=27" title="Edit section: Angiotensin-modulating agents">edit</a>]</span> <span class="mw-headline">Angiotensin-modulating agents</span></h5>
<p>ACE inhibitor (ACE) therapy is recommended for <i>all</i> patients with systolic heart failure, irrespective of symptomatic severity or blood pressure.<sup id="cite_ref-Krum-2001_33-0" class="reference"><a href="#cite_note-Krum-2001-33" title=""><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Hunt-2005_12-1" class="reference"><a href="#cite_note-Hunt-2005-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-NICECG5_34-0" class="reference"><a href="#cite_note-NICECG5-34" title=""><span>[</span>35<span>]</span></a></sup> ACE inhibitors improve symptoms, decrease mortality and reduce <a href="/wiki/Ventricular_hypertrophy" title="Ventricular hypertrophy">ventricular hypertrophy</a>. <a href="/wiki/Angiotensin_II_receptor_antagonist" title="Angiotensin II receptor antagonist">Angiotensin II receptor antagonist</a> therapy (also referred to as AT<sub>1</sub>-antagonists or angiotensin receptor blockers), particularly using <a href="/wiki/Candesartan" title="Candesartan">candesartan</a>, is an acceptable alternative if the patient is unable to tolerate ACEI therapy.<sup id="cite_ref-Granger-2003_35-0" class="reference"><a href="#cite_note-Granger-2003-35" title=""><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-Pfeffer-2003_36-0" class="reference"><a href="#cite_note-Pfeffer-2003-36" title=""><span>[</span>37<span>]</span></a></sup> ACEIs and ARBs decrease afterload by antagonizing the vasopressor effect of angiotensin, thereby decreasing the amount of work the heart must perform. It is also believed that angiotensin directly affects cardiac remodeling, and blocking its activity can thereby slow the deterioration of cardiac function.</p>
<p><a name="Diuretics" id="Diuretics"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=28" title="Edit section: Diuretics">edit</a>]</span> <span class="mw-headline">Diuretics</span></h5>
<p><a href="/wiki/Diuretic" title="Diuretic">Diuretic</a> therapy is indicated for relief of congestive symptoms. Several classes are used, with combinations reserved for severe heart failure:<sup id="cite_ref-Smith_28-1" class="reference"><a href="#cite_note-Smith-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Loop_diuretic" title="Loop diuretic">Loop diuretics</a> (e.g. <a href="/wiki/Furosemide" title="Furosemide">furosemide</a>, <a href="/wiki/Bumetanide" title="Bumetanide">bumetanide</a>) – most commonly used class in CHF, usually for moderate CHF.</li>
<li><a href="/wiki/Thiazide_diuretic" title="Thiazide diuretic" class="mw-redirect">Thiazide diuretics</a> (e.g. <a href="/wiki/Hydrochlorothiazide" title="Hydrochlorothiazide">hydrochlorothiazide</a>, <a href="/wiki/Chlorthalidone" title="Chlorthalidone" class="mw-redirect">chlorthalidone</a>, <a href="/w/index.php?title=Chlorthiazide&amp;action=edit&amp;redlink=1" class="new" title="Chlorthiazide (page does not exist)">chlorthiazide</a>) – may be useful for mild CHF, but typically used in severe CHF in combination with loop diuretics, resulting in a synergistic effect.</li>
<li><a href="/wiki/Potassium-sparing_diuretic" title="Potassium-sparing diuretic">Potassium-sparing diuretics</a> (e.g. <a href="/wiki/Amiloride" title="Amiloride">amiloride</a>) – used first-line use to correct <a href="/wiki/Hypokalaemia" title="Hypokalaemia" class="mw-redirect">hypokalaemia</a>.
<ul>
<li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a> is used as add-on therapy to ACEI plus loop diuretic in severe CHF.</li>
<li><a href="/wiki/Eplerenone" title="Eplerenone">Eplerenone</a> is specifically indicated for post-MI reduction of cardiovascular risk.</li>
</ul>
</li>
</ul>
<p>If a heart failure patient exhibits a resistance to or poor response to diuretic therapy, ultrafiltration or <a href="/wiki/Aquapheresis" title="Aquapheresis">aquapheresis</a> may be needed to achieve adequate control of fluid retention and congestion. The use of such mechanical methods of fluid removal can produce meaningful clinical benefits in patients with diuretic-resistant heart failure and may restore responsiveness to conventional doses of diuretics.<sup>9</sup></p>
<p><a name="Beta_blockers" id="Beta_blockers"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=29" title="Edit section: Beta blockers">edit</a>]</span> <span class="mw-headline">Beta blockers</span></h5>
<p>Until recently (within the last 20 years), β-blockers were contraindicated in CHF, owing to their negative inotropic effect and ability to produce <a href="/wiki/Bradycardia" title="Bradycardia">bradycardia</a> – effects which worsen heart failure. However, current guidelines recommend β-blocker therapy for patients with systolic heart failure due to left ventricular systolic dysfunction after stabilization with diuretic and ACEI therapy, irrespective of symptomatic severity or blood pressure.<sup id="cite_ref-NICECG5_34-1" class="reference"><a href="#cite_note-NICECG5-34" title=""><span>[</span>35<span>]</span></a></sup> As with ACEI therapy, the addition of a β-blocker can decrease mortality and improve left ventricular function. Several β-blockers are specifically indicated for CHF including: <a href="/wiki/Bisoprolol" title="Bisoprolol">bisoprolol</a>, <a href="/wiki/Carvedilol" title="Carvedilol">carvedilol</a>,<a href="/wiki/Nebivolol" title="Nebivolol">nebivolol</a> and extended-release <a href="/wiki/Metoprolol" title="Metoprolol">metoprolol</a>. The antagonism of β<sub>1</sub> inotropic and chronotropic effects decreases the amount of work the heart must perform. It is also thought that catecholamines and other sympathomimetics have an effect on cardiac remodeling, and blocking their activity can slow the deterioration of cardiac function.</p>
<p><a name="Positive_inotropes" id="Positive_inotropes"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=30" title="Edit section: Positive inotropes">edit</a>]</span> <span class="mw-headline">Positive inotropes</span></h5>
<p><a href="/wiki/Digoxin" title="Digoxin">Digoxin</a> (a mildly positive inotrope and negative chronotrope), once used as first-line therapy, is now reserved for control of ventricular rhythm in patients with atrial fibrillation; or where adequate control is not achieved with an ACEI, a beta blocker and a loop diuretic.<sup id="cite_ref-NICECG5_34-2" class="reference"><a href="#cite_note-NICECG5-34" title=""><span>[</span>35<span>]</span></a></sup> There is no evidence that digoxin reduces mortality in CHF, although some studies suggest a decreased rate in hospital admissions.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup> It is contraindicated in cardiac tamponade and restrictive cardiomyopathy.</p>
<p>The inotropic agent <a href="/wiki/Dobutamine" title="Dobutamine">dobutamine</a> is advised only in the short-term use of acutely decompensated heart failure, and has no other uses.<sup id="cite_ref-NICECG5_34-3" class="reference"><a href="#cite_note-NICECG5-34" title=""><span>[</span>35<span>]</span></a></sup></p>
<p>Phosphodiesterase inhibitors such as <a href="/wiki/Milrinone" title="Milrinone">milrinone</a> are sometimes utilized in severe cardiomyopathy. The mechanism of action is through inhibiting the breakdown and thereby increasing the concentration of <a href="/wiki/CAMP" title="CAMP">cAMP</a> similar to beta adrenoreceptor agonism, resulting in inotropic effects and modest diuretic effects.</p>
<p><a name="Alternative_vasodilators" id="Alternative_vasodilators"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=31" title="Edit section: Alternative vasodilators">edit</a>]</span> <span class="mw-headline">Alternative vasodilators</span></h5>
<p>The combination of <a href="/wiki/Isosorbide_dinitrate/hydralazine" title="Isosorbide dinitrate/hydralazine">isosorbide dinitrate/hydralazine</a> is the only vasodilator regimen, other than ACE inhibitors or angiotensin II receptor antagonists, with proven survival benefits. This combination appears to be particularly beneficial in CHF patients with an African American background, who respond less effectively to ACEI therapy.<sup id="cite_ref-Exner-2001_38-0" class="reference"><a href="#cite_note-Exner-2001-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-Taylor-2004_39-0" class="reference"><a href="#cite_note-Taylor-2004-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p><a name="Aldosterone_receptor_antagonists" id="Aldosterone_receptor_antagonists"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=32" title="Edit section: Aldosterone receptor antagonists">edit</a>]</span> <span class="mw-headline">Aldosterone receptor antagonists</span></h5>
<p>The RALES trial<sup id="cite_ref-Pitt-1999_40-0" class="reference"><a href="#cite_note-Pitt-1999-40" title=""><span>[</span>41<span>]</span></a></sup> showed that the addition of spironolactone can improve mortality, particularly in severe cardiomyopathy (ejection fraction less than 25%.) The related drug <a href="/wiki/Eplerenone" title="Eplerenone">eplerenone</a> was shown in the EPHESUS trial<sup id="cite_ref-Pitt-2001_41-0" class="reference"><a href="#cite_note-Pitt-2001-41" title=""><span>[</span>42<span>]</span></a></sup> to have a similar effect, and it is specifically labelled for use in decompensated heart failure complicating acute myocardial infarction. While the antagonism of aldosterone will decrease the effects of sodium and water retention, it is thought that the main mechanism of action is by antagonizing the deleterious effects of aldosterone on cardiac remodeling.</p>
<p><a name="Recombinant_neuroendocrine_hormones" id="Recombinant_neuroendocrine_hormones"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=33" title="Edit section: Recombinant neuroendocrine hormones">edit</a>]</span> <span class="mw-headline">Recombinant neuroendocrine hormones</span></h5>
<p><a href="/wiki/Nesiritide" title="Nesiritide">Nesiritide</a>, a recombinant form of B-natriuretic peptide, is indicated for use in patients with acute decompensated heart failure who have dyspnea at rest. Nesiritide promotes diuresis and natriuresis, thereby ameliorating volume overload. It is thought that, while BNP is elevated in heart failure, the peptide that is produced is actually dysfunctional or non-functional and thereby ineffective.</p>
<p><a name="Vasopressin_receptor_antagonists" id="Vasopressin_receptor_antagonists"></a></p>
<h5><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=34" title="Edit section: Vasopressin receptor antagonists">edit</a>]</span> <span class="mw-headline">Vasopressin receptor antagonists</span></h5>
<p><a href="/wiki/Tolvaptan" title="Tolvaptan">Tolvaptan</a> and <a href="/wiki/Conivaptan" title="Conivaptan">conivaptan</a> antagonize the effects of antidiuretic hormone (vasopressin), thereby promoting the specific excretion of free water, directly ameliorating the volume overloaded state, and counteracting the hyponatremia that occurs due to the release of neuroendocrine hormones in an attempt to counteract the effects of heart failure. The EVEREST trial, which utilized tolvaptan, showed that when used in combination with conventional therapy, many symptoms of acute decompensated heart failure were significantly improved compared to conventional therapy alone<sup id="cite_ref-Gheorghiade-2007_42-0" class="reference"><a href="#cite_note-Gheorghiade-2007-42" title=""><span>[</span>43<span>]</span></a></sup> although they found no difference in mortality and morbidity when compared to conventional therapy.<sup id="cite_ref-Konstam-2007_43-0" class="reference"><a href="#cite_note-Konstam-2007-43" title=""><span>[</span>44<span>]</span></a></sup>.</p>
<p><a name="Devices" id="Devices"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=35" title="Edit section: Devices">edit</a>]</span> <span class="mw-headline">Devices</span></h4>
<p>Patients with NYHA class III or IV, left ventricular ejection fraction (LVEF) of 35% or less and a QRS interval of 120 <a href="/wiki/Millisecond" title="Millisecond">ms</a> or more may benefit from cardiac resynchronization therapy (CRT; pacing both the <a href="/wiki/Left_ventricle" title="Left ventricle">left</a> and <a href="/wiki/Right_ventricle" title="Right ventricle">right ventricles</a>), through implantation of a <a href="/wiki/Artificial_pacemaker" title="Artificial pacemaker">bi-ventricular pacemaker</a>, or surgical remodeling of the heart. These treatment modalities may make the patient symptomatically better, improving quality of life and in some trials have been proven to reduce mortality.</p>
<p>The COMPANION trial demonstrated that CRT improved survival in individuals with NYHA class III or IV heart failure with a widened <a href="/wiki/QRS_complex" title="QRS complex" class="mw-redirect">QRS complex</a> on an electrocardiogram.<sup id="cite_ref-Bristow-2004_44-0" class="reference"><a href="#cite_note-Bristow-2004-44" title=""><span>[</span>45<span>]</span></a></sup> The CARE-HF trial showed that patients receiving CRT and optimal medical therapy benefited from a 36% reduction in all cause mortality, and a reduction in cardiovascular-related hospitalization.<sup id="cite_ref-Cleland-2005_45-0" class="reference"><a href="#cite_note-Cleland-2005-45" title=""><span>[</span>46<span>]</span></a></sup></p>
<p>Patients with NYHA class II, III or IV, and LVEF of 35% (without a QRS requirement) may also benefit from an <a href="/wiki/Implantable_cardioverter-defibrillator" title="Implantable cardioverter-defibrillator">implantable cardioverter-defibrillator</a> (ICD), a device that is proven to reduce all cause mortality by 23% compared to placebo in patients who were already optimally managed on drug therapy.<sup id="cite_ref-Bardy-2005_46-0" class="reference"><a href="#cite_note-Bardy-2005-46" title=""><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-pmid11907286_47-0" class="reference"><a href="#cite_note-pmid11907286-47" title=""><span>[</span>48<span>]</span></a></sup> Patients with severe cardiomyopathy are at high risk for sudden cardiac death due to ventricular dysrhythmias. Although ICDs deliver electrical shocks to resynchronize heart rhythm which are potentially destressing to the patient, they have not been shown to affect <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.<sup id="cite_ref-pmid18768943_48-0" class="reference"><a href="#cite_note-pmid18768943-48" title=""><span>[</span>49<span>]</span></a></sup> The number of (appropriate and inappropriate) shocks seems to be associated to a worse outcome.<sup id="cite_ref-pmid18768944_49-0" class="reference"><a href="#cite_note-pmid18768944-49" title=""><span>[</span>50<span>]</span></a></sup> Although they are expensive, ICDs are potentially cost-effective in this setting.<sup id="cite_ref-pmid16207849_50-0" class="reference"><a href="#cite_note-pmid16207849-50" title=""><span>[</span>51<span>]</span></a></sup></p>
<p>Another current treatment involves the use of left <a href="/wiki/Ventricular_assist_device" title="Ventricular assist device">ventricular assist devices</a> (LVADs). LVADs are battery-operated mechanical pump-type devices that are surgically implanted on the upper part of the abdomen. They take blood from the left ventricle and pump it through the aorta. LVADs are becoming more common and are often used by patients who have to wait for heart transplants.</p>
<p><a name="Surgery" id="Surgery"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=36" title="Edit section: Surgery">edit</a>]</span> <span class="mw-headline">Surgery</span></h4>
<p>The final option, if other measures have failed, is <a href="/wiki/Heart_transplantation" title="Heart transplantation">heart transplantation</a> or (temporary or prolonged) implantation of an <a href="/wiki/Artificial_heart" title="Artificial heart">artificial heart</a>. These remain the recommended surgical treatment options. However, the limited number of hearts available for transplantation in a growing group of candidates, has led to the development of alternative surgical approaches to heart failure. These commonly involve <a href="/w/index.php?title=Surgical_left_ventricular_remodeling&amp;action=edit&amp;redlink=1" class="new" title="Surgical left ventricular remodeling (page does not exist)">surgical left ventricular remodeling</a>. The aim of the procedures is to reduce the ventricle diameter (targeting <a href="/wiki/Laplace%27s_law" title="Laplace's law">Laplace's law</a> and the disease mechanism of heart failure), improve its shape and/or remove non-viable tissue.<sup id="cite_ref-pmid16087128_51-0" class="reference"><a href="#cite_note-pmid16087128-51" title=""><span>[</span>52<span>]</span></a></sup> These procedures can be performed together with <a href="/wiki/Coronary_artery_bypass_surgery" title="Coronary artery bypass surgery">coronary artery bypass surgery</a> or <a href="/wiki/Mitral_valve_repair" title="Mitral valve repair">mitral valve repair</a>.</p>
<p>If heart failure ensues after a myocardial infarction due to scarring and aneurysm formation, reconstructive surgery may be an option. These aneurysms bulge with every contraction, making it inefficient. Cooley and coworkers reported the first surgical treatment of a left ventricular aneurysm in 1958.<sup id="cite_ref-pmid13538738_52-0" class="reference"><a href="#cite_note-pmid13538738-52" title=""><span>[</span>53<span>]</span></a></sup> They used a linear closure after their excision. In the 1980s, <a href="/w/index.php?title=Vincent_Dor&amp;action=edit&amp;redlink=1" class="new" title="Vincent Dor (page does not exist)">Vincent Dor</a> developed a method using an circular patch stitched to the inside of the ventricle (the endoventricular circular patch plasty or <a href="/wiki/Dor_procedure" title="Dor procedure">Dor procedure</a>) to close the defect after excision.<sup id="cite_ref-pmid11391036_53-0" class="reference"><a href="#cite_note-pmid11391036-53" title=""><span>[</span>54<span>]</span></a></sup> His approach has been modified by others. Today, this is the preferred method for surgical treatment of incorrectly contracting (dyskinetic) left ventricle tissue, although a linear closure technique combined with septoplasty might be equally effective.<sup id="cite_ref-pmid15354107_54-0" class="reference"><a href="#cite_note-pmid15354107-54" title=""><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-pmid11279407_55-0" class="reference"><a href="#cite_note-pmid11279407-55" title=""><span>[</span>56<span>]</span></a></sup> The multicenter RESTORE trial of 1198 participants demonstrated an increase in ejection fraction from about 30% to 40% with a concomitant shift in NYHA classes, with an early mortality of 5% and a 5-year survival of 70%.<sup id="cite_ref-pmid15464325_56-0" class="reference"><a href="#cite_note-pmid15464325-56" title=""><span>[</span>57<span>]</span></a></sup> As of yet, it remains unknown if surgery is superior to optimal medical therapy. The STICH trial (Surgical Treatment for IschemiC Heart Failure) will examine the role of medical treatment, coronary artery bypass surgery and left ventricle remodeling surgery in heart failure patients. Results are expected to be published in 2009 and 2011.<sup id="cite_ref-pmid18023680_57-0" class="reference"><a href="#cite_note-pmid18023680-57" title=""><span>[</span>58<span>]</span></a></sup></p>
<p>The <a href="/wiki/Batista_procedure" title="Batista procedure">Batista procedure</a> was invented by Brazilian doctor <a href="/w/index.php?title=Randas_Batista&amp;action=edit&amp;redlink=1" class="new" title="Randas Batista (page does not exist)">Randas Batista</a> in 1994 for use in patients with non-ischemic <a href="/wiki/Dilated_cardiomyopathy" title="Dilated cardiomyopathy">dilated cardiomyopathy</a>. It involves removal of a portion of viable tissue from the left ventricle to reduce its size (partial left ventriculectomy), with or without repair or replacement of the mitral valve.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58" title=""><span>[</span>59<span>]</span></a></sup>. Although several studies showed benefits from this surgery, studies at the <a href="/wiki/Cleveland_Clinic" title="Cleveland Clinic">Cleveland Clinic</a> concluded that this procedure was associated with a high early and late failure rate. At 3 years only 26 percent were event-free and survival rate was only 60 percent.<sup id="cite_ref-pmid11326231_59-0" class="reference"><a href="#cite_note-pmid11326231-59" title=""><span>[</span>60<span>]</span></a></sup> Most hospitals have abandoned this operation and it is no longer included in heart failure guidelines.<sup id="cite_ref-pmid16087128_51-1" class="reference"><a href="#cite_note-pmid16087128-51" title=""><span>[</span>52<span>]</span></a></sup></p>
<p>Newer procedures under examination are based on the observation that the spherical configuration of the dilated heart reduces ejection fraction compared to the elliptical form. Mesh-like constraint devices such as the <a href="/w/index.php?title=Acorn_CorCap&amp;action=edit&amp;redlink=1" class="new" title="Acorn CorCap (page does not exist)">Acorn CorCap</a> aim to improve contraction efficacy and prevent further remodeling. Clinical trials are underway.<sup id="cite_ref-pmid14566236_60-0" class="reference"><a href="#cite_note-pmid14566236-60" title=""><span>[</span>61<span>]</span></a></sup> Another technique which aims to divide the spherical ventricle into two elliptical halves is used with the <a href="/w/index.php?title=Myosplint&amp;action=edit&amp;redlink=1" class="new" title="Myosplint (page does not exist)">Myosplint</a> device.<sup id="cite_ref-pmid12057702_61-0" class="reference"><a href="#cite_note-pmid12057702-61" title=""><span>[</span>62<span>]</span></a></sup></p>
<p><a name="Approach" id="Approach"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=37" title="Edit section: Approach">edit</a>]</span> <span class="mw-headline">Approach</span></h3>
<p><a name="Acute_decompensation" id="Acute_decompensation"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=38" title="Edit section: Acute decompensation">edit</a>]</span> <span class="mw-headline">Acute decompensation</span></h4>
<dl>
<dd><i>See main article: <a href="/wiki/Acute_decompensated_heart_failure" title="Acute decompensated heart failure">Acute decompensated heart failure</a></i><br /></dd>
</dl>
<p>In <a href="/wiki/Acute_decompensated_heart_failure" title="Acute decompensated heart failure">acute decompensated heart failure</a> (ADHF), the immediate goal is to re-establish adequate perfusion and oxygen delivery to end organs. This entails ensuring that <a href="/wiki/ABC_(medicine)" title="ABC (medicine)">airway, breathing, and circulation</a> are adequate.</p>
<p><a name="Chronic_management" id="Chronic_management"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=39" title="Edit section: Chronic management">edit</a>]</span> <span class="mw-headline">Chronic management</span></h4>
<p>The goal is to prevent the development of acute decompensated heart failure, to counteract the deleterious effects of cardiac remodeling, and to minimize the symptoms that the patient suffers. In addition to pharmacologic agents (oral loop diuretics, <a href="/wiki/Beta-blockers" title="Beta-blockers" class="mw-redirect">beta-blockers</a>, <a href="/wiki/ACE_inhibitors" title="ACE inhibitors" class="mw-redirect">ACE inhibitors</a> or <a href="/wiki/Angiotensin" title="Angiotensin">angiotensin</a> receptor blockers, vasodilators, and in severe cardiomyopathy <a href="/wiki/Aldosterone_antagonist" title="Aldosterone antagonist">aldosterone receptor antagonists</a>), behavioral modification should be pursued, specifically with regards to dietary guidelines regarding salt and fluid intake. Exercise should be encouraged as tolerated, as sufficient conditioning can significantly improve quality-of-life.</p>
<p>In patients with severe cardiomyopathy, implantation of an <a href="/wiki/Implantable_cardioverter-defibrillator" title="Implantable cardioverter-defibrillator">automatic implantable cardioverter defibrillator</a>(AICD) should be considered. A select population will also probably benefit from <a href="/wiki/Artificial_pacemaker#Biventricular_Pacing_.28BVP.29" title="Artificial pacemaker">ventricular resynchronization</a>.</p>
<p>In select cases, <a href="/wiki/Cardiac_transplantation" title="Cardiac transplantation" class="mw-redirect">cardiac transplantation</a> can be considered. While this may resolve the problems associated with heart failure, the patient generally must remain on an immunosuppressive regimen to prevent rejection, which has its own significant downsides.</p>
<p><a name="Palliative_care_and_hospice" id="Palliative_care_and_hospice"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=40" title="Edit section: Palliative care and hospice">edit</a>]</span> <span class="mw-headline">Palliative care and hospice</span></h4>
<p>Without transplantation, heart failure caused by ischemic heart disease is not reversible, and cardiac function typically deteriorates with time. (In particular, diastolic function worsens as a function of age even in individuals without ischemic heart disease.) The growing number of patients with Stage D heart failure (intractable symptoms of fatigue, shortness of breath or chest pain at rest despite optimal medical therapy) should be considered for palliative care or hospice, according to American College of Cardiology/American Heart Association guidelines.</p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=41" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<p>Prognosis in heart failure can be assessed in multiple ways including clinical prediction rules and cardiopulmonary exercise testing. Clinical prediction rules use a composite of clinical factors such as lab tests and blood pressure to estimate prognosis. Among several <a href="/wiki/Clinical_prediction_rule" title="Clinical prediction rule">clinical prediction rules</a> for prognosing acute heart failure, the 'EFFECT rule' slightly outperformed other rules in stratifying patients and identifying those at low risk of death during hospitalization or within 30 days.<sup id="cite_ref-pmid17449141_62-0" class="reference"><a href="#cite_note-pmid17449141-62" title=""><span>[</span>63<span>]</span></a></sup> Easy methods for identifying low risk patients are:</p>
<ul>
<li>ADHERE Tree rule indicates that patients with <a href="/wiki/Blood_urea_nitrogen" title="Blood urea nitrogen">blood urea nitrogen</a> &lt; 43&#160;mg/dl and <a href="/wiki/Systolic_blood_pressure" title="Systolic blood pressure" class="mw-redirect">systolic blood pressure</a> at least 115&#160;mm Hg have less than 10% chance of inpatient death or complications.</li>
<li>BWH rule indicates that patients with systolic blood pressure over 90&#160;mm Hg, respiratory rate of 30 or less breaths per minute, serum sodium over 135&#160;mmol/L, no new ST-T wave changes have less than 10% chance of inpatient death or complications.</li>
</ul>
<p>A very important method for assessing prognosis in advanced heart failure patients is cardiopulmonary exercise testing (CPX testing). CPX testing is usually required prior to heart transplantation as an indicator of prognosis. Cardiopulmonary exercise testing involves measurement of exhaled oxygen and carbon dioxide during exercise. The peak oxygen consumption (VO2 max) is used as an indicator of prognosis. As a general rule, a VO2 max less than 12-14 cc/kg/min indicates a poorer survival and suggests that the patient may be a candidate for a heart transplant. Patients with a VO2 max&lt;10 cc/kg/min have clearly poorer prognosis. The most recent International Society for Heart and Lung Transplantation (ISHLT) guidelines (<a href="http://www.jhltonline.org/article/PIIS1053249806004608/fulltext#sec1" class="external free" title="http://www.jhltonline.org/article/PIIS1053249806004608/fulltext#sec1" rel="nofollow">http://www.jhltonline.org/article/PIIS1053249806004608/fulltext#sec1</a>) also suggest two other parameters that can be used for evaluation of prognosis in advanced heart failure, the heart failure survival score and the use of a criteria of VE/VCO2 slope&gt;35 from the CPX test. The heart failure survival score is a score calculated using a combination of clinical predictors and the VO2 max from the cardiopulmonary exercise test.</p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=42" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<table class="metadata plainlinks ambox mbox-small-left ambox-notice" style="margin: 4px 1em 4px 0; width: 238px; border-collapse: collapse; font-size: 88%; line-height: 1.25em;">
<tr>
<td class="mbox-image"><a href="/wiki/File:Wiki_letter_w.svg" class="image" title="Wiki letter w.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Wiki_letter_w.svg/20px-Wiki_letter_w.svg.png" width="20" height="20" border="0" /></a></td>
<td class="mbox-text" style="">This section requires <a href="http://en.wikipedia.org/w/index.php?title=Heart_failure&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Heart_failure&amp;action=edit" rel="nofollow">expansion</a>.</td>
</tr>
</table>
<p>Heart failure is the leading cause of hospitalization in people older than 65.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63" title=""><span>[</span>64<span>]</span></a></sup> In developed countries, the mean age of patients with heart failure is 75 years old.<sup id="cite_ref-pmid12034163_3-1" class="reference"><a href="#cite_note-pmid12034163-3" title=""><span>[</span>4<span>]</span></a></sup> In developing countries, two to three percent of the population suffers from heart failure, but in those 70 to 80 years old, it occurs in 20—30 percent.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=43" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Cardiogenic_shock" title="Cardiogenic shock">Cardiogenic shock</a></li>
<li><a href="/wiki/Heart_transplant" title="Heart transplant" class="mw-redirect">Heart transplant</a></li>
<li><a href="/wiki/Dor_procedure" title="Dor procedure">Dor procedure</a></li>
<li><a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE inhibitor</a></li>
<li><a href="/wiki/Isosorbide_dinitrate/hydralazine" title="Isosorbide dinitrate/hydralazine">Isosorbide dinitrate/hydralazine</a></li>
<li><a href="/wiki/Killip_class" title="Killip class">Killip class</a></li>
<li><a href="/wiki/Ventricular_remodeling" title="Ventricular remodeling">Ventricular remodeling</a></li>
<li><a href="/wiki/Fluid_overload" title="Fluid overload" class="mw-redirect">Fluid overload</a></li>
<li><a href="/w/index.php?title=Framingham_criteria&amp;action=edit&amp;redlink=1" class="new" title="Framingham criteria (page does not exist)">Framingham criteria</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=44" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> <i><a href="http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/four/000047501.htm" class="external text" title="http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/four/000047501.htm" rel="nofollow">heart failure</a></i> at <a href="/wiki/Dorland%27s_Medical_Dictionary" title="Dorland's Medical Dictionary" class="mw-redirect">Dorland's Medical Dictionary</a></li>
<li id="cite_note-Lancet2005-1">^ <a href="#cite_ref-Lancet2005_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2005_1-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2005_1-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMcMurray_JJ.2C_Pfeffer_MA2005">McMurray JJ, Pfeffer MA (2005). "Heart failure". <i>Lancet</i> <b>365</b> (9474): 1877–89. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2805%2966621-4" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2805%2966621-4" rel="nofollow">10.1016/S0140-6736(05)66621-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15924986" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15924986">PMID 15924986</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Heart+failure&amp;rft.jtitle=Lancet&amp;rft.aulast=McMurray+JJ%2C+Pfeffer+MA&amp;rft.au=McMurray+JJ%2C+Pfeffer+MA&amp;rft.date=2005&amp;rft.volume=365&amp;rft.issue=9474&amp;rft.pages=1877%E2%80%9389&amp;rft_id=info:doi/10.1016%2FS0140-6736%2805%2966621-4&amp;rft_id=info:pmid/15924986&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18799522-2"><b><a href="#cite_ref-pmid18799522_2-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDickstein_K.2C_Cohen-Solal_A.2C_Filippatos_G.2C_.27.27et_al.27.272008">Dickstein K, Cohen-Solal A, Filippatos G, <i>et al</i> (October 2008). "<a href="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=18799522" class="external text" title="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=18799522" rel="nofollow">ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)</a>". <i>Eur. Heart J.</i> <b>29</b> (19): 2388–442. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Feurheartj%2Fehn309" class="external text" title="http://dx.doi.org/10.1093%2Feurheartj%2Fehn309" rel="nofollow">10.1093/eurheartj/ehn309</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18799522" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18799522">PMID 18799522</a><span class="printonly">. <a href="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=18799522" class="external free" title="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=18799522" rel="nofollow">http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=18799522</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ESC+Guidelines+for+the+diagnosis+and+treatment+of+acute+and+chronic+heart+failure+2008%3A+the+Task+Force+for+the+Diagnosis+and+Treatment+of+Acute+and+Chronic+Heart+Failure+2008+of+the+European+Society+of+Cardiology.+Developed+in+collaboration+with+the+Heart+Failure+Association+of+the+ESC+%28HFA%29+and+endorsed+by+the+European+Society+of+Intensive+Care+Medicine+%28ESICM%29&amp;rft.jtitle=Eur.+Heart+J.&amp;rft.aulast=Dickstein+K%2C+Cohen-Solal+A%2C+Filippatos+G%2C+%27%27et+al%27%27&amp;rft.au=Dickstein+K%2C+Cohen-Solal+A%2C+Filippatos+G%2C+%27%27et+al%27%27&amp;rft.date=October+2008&amp;rft.volume=29&amp;rft.issue=19&amp;rft.pages=2388%E2%80%93442&amp;rft_id=info:doi/10.1093%2Feurheartj%2Fehn309&amp;rft_id=info:pmid/18799522&amp;rft_id=http%3A%2F%2Feurheartj.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D18799522&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12034163-3">^ <a href="#cite_ref-pmid12034163_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12034163_3-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFStewart_S.2C_Jenkins_A.2C_Buchan_S.2C_McGuire_A.2C_Capewell_S.2C_McMurray_JJ2002">Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ (June 2002). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S1388984201001982" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S1388984201001982" rel="nofollow">The current cost of heart failure to the National Health Service in the UK</a>". <i>Eur. J. Heart Fail.</i> <b>4</b> (3): 361–71. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12034163" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12034163">PMID 12034163</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S1388984201001982" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S1388984201001982" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S1388984201001982</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+current+cost+of+heart+failure+to+the+National+Health+Service+in+the+UK&amp;rft.jtitle=Eur.+J.+Heart+Fail.&amp;rft.aulast=Stewart+S%2C+Jenkins+A%2C+Buchan+S%2C+McGuire+A%2C+Capewell+S%2C+McMurray+JJ&amp;rft.au=Stewart+S%2C+Jenkins+A%2C+Buchan+S%2C+McGuire+A%2C+Capewell+S%2C+McMurray+JJ&amp;rft.date=June+2002&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=361%E2%80%9371&amp;rft_id=info:pmid/12034163&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1388984201001982&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18086926-4"><b><a href="#cite_ref-pmid18086926_4-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRosamond_W.2C_Flegal_K.2C_Furie_K.2C_.27.27et_al.27.272008">Rosamond W, Flegal K, Furie K, <i>et al</i> (January 2008). "<a href="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18086926" class="external text" title="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18086926" rel="nofollow">Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee</a>". <i>Circulation</i> <b>117</b> (4): e25–146. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.107.187998" class="external text" title="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.107.187998" rel="nofollow">10.1161/CIRCULATIONAHA.107.187998</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18086926" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18086926">PMID 18086926</a><span class="printonly">. <a href="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18086926" class="external free" title="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18086926" rel="nofollow">http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18086926</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Heart+disease+and+stroke+statistics--2008+update%3A+a+report+from+the+American+Heart+Association+Statistics+Committee+and+Stroke+Statistics+Subcommittee&amp;rft.jtitle=Circulation&amp;rft.aulast=Rosamond+W%2C+Flegal+K%2C+Furie+K%2C+%27%27et+al%27%27&amp;rft.au=Rosamond+W%2C+Flegal+K%2C+Furie+K%2C+%27%27et+al%27%27&amp;rft.date=January+2008&amp;rft.volume=117&amp;rft.issue=4&amp;rft.pages=e25%E2%80%93146&amp;rft_id=info:doi/10.1161%2FCIRCULATIONAHA.107.187998&amp;rft_id=info:pmid/18086926&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D18086926&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11847161-5"><b><a href="#cite_ref-pmid11847161_5-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJuenger_J.2C_Schellberg_D.2C_Kraemer_S.2C_.27.27et_al.27.272002">Juenger J, Schellberg D, Kraemer S, <i>et al</i> (March 2002). "<a href="http://heart.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11847161" class="external text" title="http://heart.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11847161" rel="nofollow">Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables</a>". <i>Heart</i> <b>87</b> (3): 235–41. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11847161" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11847161">PMID 11847161</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1767036" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1767036" rel="nofollow">1767036</a><span class="printonly">. <a href="http://heart.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11847161" class="external free" title="http://heart.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11847161" rel="nofollow">http://heart.bmj.com/cgi/pmidlookup?view=long&amp;pmid=11847161</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Health+related+quality+of+life+in+patients+with+congestive+heart+failure%3A+comparison+with+other+chronic+diseases+and+relation+to+functional+variables&amp;rft.jtitle=Heart&amp;rft.aulast=Juenger+J%2C+Schellberg+D%2C+Kraemer+S%2C+%27%27et+al%27%27&amp;rft.au=Juenger+J%2C+Schellberg+D%2C+Kraemer+S%2C+%27%27et+al%27%27&amp;rft.date=March+2002&amp;rft.volume=87&amp;rft.issue=3&amp;rft.pages=235%E2%80%9341&amp;rft_id=info:pmid/11847161&amp;rft_id=http%3A%2F%2Fheart.bmj.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11847161&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12445536-6"><b><a href="#cite_ref-pmid12445536_6-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHobbs_FD.2C_Kenkre_JE.2C_Roalfe_AK.2C_Davis_RC.2C_Hare_R.2C_Davies_MK2002">Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK (December 2002). "<a href="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12445536" class="external text" title="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12445536" rel="nofollow">Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population</a>". <i>Eur. Heart J.</i> <b>23</b> (23): 1867–76. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12445536" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12445536">PMID 12445536</a><span class="printonly">. <a href="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12445536" class="external free" title="http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12445536" rel="nofollow">http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12445536</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Impact+of+heart+failure+and+left+ventricular+systolic+dysfunction+on+quality+of+life%3A+a+cross-sectional+study+comparing+common+chronic+cardiac+and+medical+disorders+and+a+representative+adult+population&amp;rft.jtitle=Eur.+Heart+J.&amp;rft.aulast=Hobbs+FD%2C+Kenkre+JE%2C+Roalfe+AK%2C+Davis+RC%2C+Hare+R%2C+Davies+MK&amp;rft.au=Hobbs+FD%2C+Kenkre+JE%2C+Roalfe+AK%2C+Davis+RC%2C+Hare+R%2C+Davies+MK&amp;rft.date=December+2002&amp;rft.volume=23&amp;rft.issue=23&amp;rft.pages=1867%E2%80%9376&amp;rft_id=info:pmid/12445536&amp;rft_id=http%3A%2F%2Feurheartj.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D12445536&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-neubauer-2007-7"><b><a href="#cite_ref-neubauer-2007_7-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNeubauer_S2007">Neubauer S (2007). "The failing heart — an engine out of fuel". <i>N Engl J Med</i> <b>356</b> (11): 1140–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMra063052" class="external text" title="http://dx.doi.org/10.1056%2FNEJMra063052" rel="nofollow">10.1056/NEJMra063052</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17360992" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17360992">PMID 17360992</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+failing+heart+%E2%80%94+an+engine+out+of+fuel&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Neubauer+S&amp;rft.au=Neubauer+S&amp;rft.date=2007&amp;rft.volume=356&amp;rft.issue=11&amp;rft.pages=1140%E2%80%9351&amp;rft_id=info:doi/10.1056%2FNEJMra063052&amp;rft_id=info:pmid/17360992&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <i><a href="http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/nine/000953448.htm" class="external text" title="http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/nine/000953448.htm" rel="nofollow">congestive heart failure</a></i> at <a href="/wiki/Dorland%27s_Medical_Dictionary" title="Dorland's Medical Dictionary" class="mw-redirect">Dorland's Medical Dictionary</a></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <i><a href="http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/nine/000953450.htm" class="external text" title="http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/nine/000953450.htm" rel="nofollow">high-output heart failure</a></i> at <a href="/wiki/Dorland%27s_Medical_Dictionary" title="Dorland's Medical Dictionary" class="mw-redirect">Dorland's Medical Dictionary</a></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> Criteria Committee, New York Heart Association. <i>Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis, 6th ed.</i> Boston: Little, Brown and co, 1964;114.</li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRaphael_C.2C_Briscoe_C.2C_Davies_J.2C_.27.27et_al.27.272007">Raphael C, Briscoe C, Davies J, <i>et al</i> (2007). "Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure". <i>Heart</i> <b>93</b> (4): 476–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fhrt.2006.089656" class="external text" title="http://dx.doi.org/10.1136%2Fhrt.2006.089656" rel="nofollow">10.1136/hrt.2006.089656</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17005715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17005715">PMID 17005715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Limitations+of+the+New+York+Heart+Association+functional+classification+system+and+self-reported+walking+distances+in+chronic+heart+failure&amp;rft.jtitle=Heart&amp;rft.aulast=Raphael+C%2C+Briscoe+C%2C+Davies+J%2C+%27%27et+al%27%27&amp;rft.au=Raphael+C%2C+Briscoe+C%2C+Davies+J%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=93&amp;rft.issue=4&amp;rft.pages=476%E2%80%9382&amp;rft_id=info:doi/10.1136%2Fhrt.2006.089656&amp;rft_id=info:pmid/17005715&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Hunt-2005-12">^ <a href="#cite_ref-Hunt-2005_12-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hunt-2005_12-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHunt_SA.2C_Abraham_WT.2C_Chin_MH.2C_.27.27et_al.27.272005">Hunt SA, Abraham WT, Chin MH, <i>et al</i> (2005). "<a href="http://circ.ahajournals.org/cgi/reprint/112/12/e154.pdf" class="external text" title="http://circ.ahajournals.org/cgi/reprint/112/12/e154.pdf" rel="nofollow">ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult</a>" (PDF). <i>Circulation</i> <b>112</b> (12): e154–235. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.105.167586" class="external text" title="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.105.167586" rel="nofollow">10.1161/CIRCULATIONAHA.105.167586</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16160202" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16160202">PMID 16160202</a><span class="printonly">. <a href="http://circ.ahajournals.org/cgi/reprint/112/12/e154.pdf" class="external free" title="http://circ.ahajournals.org/cgi/reprint/112/12/e154.pdf" rel="nofollow">http://circ.ahajournals.org/cgi/reprint/112/12/e154.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ACC%2FAHA+2005+Guideline+Update+for+the+Diagnosis+and+Management+of+Chronic+Heart+Failure+in+the+Adult&amp;rft.jtitle=Circulation&amp;rft.aulast=Hunt+SA%2C+Abraham+WT%2C+Chin+MH%2C+%27%27et+al%27%27&amp;rft.au=Hunt+SA%2C+Abraham+WT%2C+Chin+MH%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=112&amp;rft.issue=12&amp;rft.pages=e154%E2%80%93235&amp;rft_id=info:doi/10.1161%2FCIRCULATIONAHA.105.167586&amp;rft_id=info:pmid/16160202&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Freprint%2F112%2F12%2Fe154.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcKee_PA.2C_Castelli_WP.2C_McNamara_PM.2C_Kannel_WB1971">McKee PA, Castelli WP, McNamara PM, Kannel WB (1971). "The natural history of congestive heart failure: the Framingham study". <i>N. Engl. J. Med.</i> <b>285</b> (26): 1441–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/5122894" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/5122894">PMID 5122894</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+natural+history+of+congestive+heart+failure%3A+the+Framingham+study&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=McKee+PA%2C+Castelli+WP%2C+McNamara+PM%2C+Kannel+WB&amp;rft.au=McKee+PA%2C+Castelli+WP%2C+McNamara+PM%2C+Kannel+WB&amp;rft.date=1971&amp;rft.volume=285&amp;rft.issue=26&amp;rft.pages=1441%E2%80%936&amp;rft_id=info:pmid/5122894&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCarlson_KJ.2C_Lee_DC.2C_Goroll_AH.2C_Leahy_M.2C_Johnson_RA1985">Carlson KJ, Lee DC, Goroll AH, Leahy M, Johnson RA (1985). "An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients". <i>Journal of chronic diseases</i> <b>38</b> (9): 733–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0021-9681%2885%2990115-8" class="external text" title="http://dx.doi.org/10.1016%2F0021-9681%2885%2990115-8" rel="nofollow">10.1016/0021-9681(85)90115-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/4030999" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/4030999">PMID 4030999</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+analysis+of+physicians%27+reasons+for+prescribing+long-term+digitalis+therapy+in+outpatients&amp;rft.jtitle=Journal+of+chronic+diseases&amp;rft.aulast=Carlson+KJ%2C+Lee+DC%2C+Goroll+AH%2C+Leahy+M%2C+Johnson+RA&amp;rft.au=Carlson+KJ%2C+Lee+DC%2C+Goroll+AH%2C+Leahy+M%2C+Johnson+RA&amp;rft.date=1985&amp;rft.volume=38&amp;rft.issue=9&amp;rft.pages=733%E2%80%939&amp;rft_id=info:doi/10.1016%2F0021-9681%2885%2990115-8&amp;rft_id=info:pmid/4030999&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHarlan_WR.2C_oberman_A.2C_Grimm_R.2C_Rosati_RA1977">Harlan WR, oberman A, Grimm R, Rosati RA (1977). "Chronic congestive heart failure in coronary artery disease: clinical criteria". <i>Ann. Intern. Med.</i> <b>86</b> (2): 133–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/835934" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/835934">PMID 835934</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chronic+congestive+heart+failure+in+coronary+artery+disease%3A+clinical+criteria&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.aulast=Harlan+WR%2C+oberman+A%2C+Grimm+R%2C+Rosati+RA&amp;rft.au=Harlan+WR%2C+oberman+A%2C+Grimm+R%2C+Rosati+RA&amp;rft.date=1977&amp;rft.volume=86&amp;rft.issue=2&amp;rft.pages=133%E2%80%938&amp;rft_id=info:pmid/835934&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKillip_T.2C_Kimball_JT1967">Killip T, Kimball JT (1967). "Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients". <i>Am. J. Cardiol.</i> <b>20</b> (4): 457–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0002-9149%2867%2990023-9" class="external text" title="http://dx.doi.org/10.1016%2F0002-9149%2867%2990023-9" rel="nofollow">10.1016/0002-9149(67)90023-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6059183" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6059183">PMID 6059183</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+myocardial+infarction+in+a+coronary+care+unit.+A+two+year+experience+with+250+patients&amp;rft.jtitle=Am.+J.+Cardiol.&amp;rft.aulast=Killip+T%2C+Kimball+JT&amp;rft.au=Killip+T%2C+Kimball+JT&amp;rft.date=1967&amp;rft.volume=20&amp;rft.issue=4&amp;rft.pages=457%E2%80%9364&amp;rft_id=info:doi/10.1016%2F0002-9149%2867%2990023-9&amp;rft_id=info:pmid/6059183&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHe_J.3B_Ogden_LG.3B_Bazzano_LA.3B_Vupputuri_S.2C_.27.27et_al.27.272001">He J; Ogden LG; Bazzano LA; Vupputuri S, <i>et al</i> (2001). "Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.". <i>Arch. Intern. Med.</i> <b>161</b> (7): 996–1002. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.161.7.996" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.161.7.996" rel="nofollow">10.1001/archinte.161.7.996</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11295963" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11295963">PMID 11295963</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Risk+factors+for+congestive+heart+failure+in+US+men+and+women%3A+NHANES+I+epidemiologic+follow-up+study.&amp;rft.jtitle=Arch.+Intern.+Med.&amp;rft.aulast=He+J%3B+Ogden+LG%3B+Bazzano+LA%3B+Vupputuri+S%2C+%27%27et+al%27%27&amp;rft.au=He+J%3B+Ogden+LG%3B+Bazzano+LA%3B+Vupputuri+S%2C+%27%27et+al%27%27&amp;rft.date=2001&amp;rft.volume=161&amp;rft.issue=7&amp;rft.pages=996%E2%80%931002&amp;rft_id=info:doi/10.1001%2Farchinte.161.7.996&amp;rft_id=info:pmid/11295963&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBaldasseroni_S.3B_Opasich_C.3B_Gorini_M.3B_Lucci_D.2C_.27.27et_al.27.272002">Baldasseroni S; Opasich C; Gorini M; Lucci D, <i>et al</i> (2002). "Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.". <i>American Heart Journal</i> <b>143</b> (3): 398–405. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1067%2Fmhj.2002.121264" class="external text" title="http://dx.doi.org/10.1067%2Fmhj.2002.121264" rel="nofollow">10.1067/mhj.2002.121264</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11868043" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11868043">PMID 11868043</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Left+bundle-branch+block+is+associated+with+increased+1-year+sudden+and+total+mortality+rate+in+5517+outpatients+with+congestive+heart+failure%3A+a+report+from+the+Italian+network+on+congestive+heart+failure.&amp;rft.jtitle=American+Heart+Journal&amp;rft.aulast=Baldasseroni+S%3B+Opasich+C%3B+Gorini+M%3B+Lucci+D%2C+%27%27et+al%27%27&amp;rft.au=Baldasseroni+S%3B+Opasich+C%3B+Gorini+M%3B+Lucci+D%2C+%27%27et+al%27%27&amp;rft.date=2002&amp;rft.volume=143&amp;rft.issue=3&amp;rft.pages=398%E2%80%93405&amp;rft_id=info:doi/10.1067%2Fmhj.2002.121264&amp;rft_id=info:pmid/11868043&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-OPTIMIZE-HF-19"><b><a href="#cite_ref-OPTIMIZE-HF_19-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFonarow_GC.2C_Abraham_WT.2C_Albert_NM.2C_.27.27et_al.27.272008">Fonarow GC, Abraham WT, Albert NM, <i>et al</i> (April 2008). "Factors Identified as Precipitating Hospital Admissions for Heart Failure and Clinical Outcomes: Findings From OPTIMIZE-HF". <i>Arch. Intern. Med.</i> <b>168</b> (8): 847–854. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.168.8.847" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.168.8.847" rel="nofollow">10.1001/archinte.168.8.847</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18443260" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18443260">PMID 18443260</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Factors+Identified+as+Precipitating+Hospital+Admissions+for+Heart+Failure+and+Clinical+Outcomes%3A+Findings+From+OPTIMIZE-HF&amp;rft.jtitle=Arch.+Intern.+Med.&amp;rft.aulast=Fonarow+GC%2C+Abraham+WT%2C+Albert+NM%2C+%27%27et+al%27%27&amp;rft.au=Fonarow+GC%2C+Abraham+WT%2C+Albert+NM%2C+%27%27et+al%27%27&amp;rft.date=April+2008&amp;rft.volume=168&amp;rft.issue=8&amp;rft.pages=847%E2%80%93854&amp;rft_id=info:doi/10.1001%2Farchinte.168.8.847&amp;rft_id=info:pmid/18443260&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNieminen_MS.2C_B.C3.B6hm_M.2C_Cowie_MR.2C_.27.27et_al.27.272005">Nieminen MS, Böhm M, Cowie MR, <i>et al</i> (February 2005). "<a href="http://eurheartj.oxfordjournals.org/cgi/content/full/26/4/384" class="external text" title="http://eurheartj.oxfordjournals.org/cgi/content/full/26/4/384" rel="nofollow">Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology</a>". <i>Eur. Heart J.</i> <b>26</b> (4): 384–416. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Feurheartj%2Fehi044" class="external text" title="http://dx.doi.org/10.1093%2Feurheartj%2Fehi044" rel="nofollow">10.1093/eurheartj/ehi044</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15681577" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15681577">PMID 15681577</a><span class="printonly">. <a href="http://eurheartj.oxfordjournals.org/cgi/content/full/26/4/384" class="external free" title="http://eurheartj.oxfordjournals.org/cgi/content/full/26/4/384" rel="nofollow">http://eurheartj.oxfordjournals.org/cgi/content/full/26/4/384</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Executive+summary+of+the+guidelines+on+the+diagnosis+and+treatment+of+acute+heart+failure%3A+the+Task+Force+on+Acute+Heart+Failure+of+the+European+Society+of+Cardiology&amp;rft.jtitle=Eur.+Heart+J.&amp;rft.aulast=Nieminen+MS%2C+B%C3%B6hm+M%2C+Cowie+MR%2C+%27%27et+al%27%27&amp;rft.au=Nieminen+MS%2C+B%C3%B6hm+M%2C+Cowie+MR%2C+%27%27et+al%27%27&amp;rft.date=February+2005&amp;rft.volume=26&amp;rft.issue=4&amp;rft.pages=384%E2%80%93416&amp;rft_id=info:doi/10.1093%2Feurheartj%2Fehi044&amp;rft_id=info:pmid/15681577&amp;rft_id=http%3A%2F%2Feurheartj.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F26%2F4%2F384&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <i>Boron and Boulpaep</i> 2005 Medical Physiology Updated Edition p533 <a href="/wiki/Special:BookSources/0721632564" class="internal">ISBN 0721632564</a></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <i><a href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=617611316" class="external text" title="http://www.gpnotebook.co.uk/simplepage.cfm?ID=617611316" rel="nofollow">cardiac pathophysiology in heart failure</a></i> at <a href="/wiki/GPnotebook" title="GPnotebook">GPnotebook</a></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShigeyama_J.2C_Yasumura_Y.2C_Sakamoto_A.2C_.27.27et_al.27.272005">Shigeyama J, Yasumura Y, Sakamoto A, <i>et al</i> (December 2005). "Increased gene expression of collagen Types I and III is inhibited by beta-receptor blockade in patients with dilated cardiomyopathy". <i>Eur. Heart J.</i> <b>26</b> (24): 2698–705. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Feurheartj%2Fehi492" class="external text" title="http://dx.doi.org/10.1093%2Feurheartj%2Fehi492" rel="nofollow">10.1093/eurheartj/ehi492</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16204268" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16204268">PMID 16204268</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Increased+gene+expression+of+collagen+Types+I+and+III+is+inhibited+by+beta-receptor+blockade+in+patients+with+dilated+cardiomyopathy&amp;rft.jtitle=Eur.+Heart+J.&amp;rft.aulast=Shigeyama+J%2C+Yasumura+Y%2C+Sakamoto+A%2C+%27%27et+al%27%27&amp;rft.au=Shigeyama+J%2C+Yasumura+Y%2C+Sakamoto+A%2C+%27%27et+al%27%27&amp;rft.date=December+2005&amp;rft.volume=26&amp;rft.issue=24&amp;rft.pages=2698%E2%80%93705&amp;rft_id=info:doi/10.1093%2Feurheartj%2Fehi492&amp;rft_id=info:pmid/16204268&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTsutsui_H.2C_Matsushima_S.2C_Kinugawa_S.2C_.27.27et_al.27.272007">Tsutsui H, Matsushima S, Kinugawa S, <i>et al</i> (May 2007). "<a href="http://joi.jlc.jst.go.jp/JST.JSTAGE/hypres/30.439?from=PubMed" class="external text" title="http://joi.jlc.jst.go.jp/JST.JSTAGE/hypres/30.439?from=PubMed" rel="nofollow">Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart</a>" (<sup class="noprint Inline-Template"><span title="&#160;since June 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Dead_external_links" title="Wikipedia:Dead external links">dead link</a></i>]</span></sup> – <sup><a href="http://scholar.google.co.uk/scholar?hl=en&amp;lr=&amp;q=intitle%3AAngiotensin+II+type+1+receptor+blocker+attenuates+myocardial+remodeling+and+preserves+diastolic+function+in+diabetic+heart&amp;as_publication=Hypertens.+Res.&amp;as_ylo=2007&amp;as_yhi=2007&amp;btnG=Search" class="external text" title="http://scholar.google.co.uk/scholar?hl=en&amp;lr=&amp;q=intitle%3AAngiotensin+II+type+1+receptor+blocker+attenuates+myocardial+remodeling+and+preserves+diastolic+function+in+diabetic+heart&amp;as_publication=Hypertens.+Res.&amp;as_ylo=2007&amp;as_yhi=2007&amp;btnG=Search" rel="nofollow">Scholar search</a></sup>). <i>Hypertens. Res.</i> <b>30</b> (5): 439–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1291%2Fhypres.30.439" class="external text" title="http://dx.doi.org/10.1291%2Fhypres.30.439" rel="nofollow">10.1291/hypres.30.439</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17587756" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17587756">PMID 17587756</a><span class="printonly">. <a href="http://joi.jlc.jst.go.jp/JST.JSTAGE/hypres/30.439?from=PubMed" class="external free" title="http://joi.jlc.jst.go.jp/JST.JSTAGE/hypres/30.439?from=PubMed" rel="nofollow">http://joi.jlc.jst.go.jp/JST.JSTAGE/hypres/30.439?from=PubMed</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Angiotensin+II+type+1+receptor+blocker+attenuates+myocardial+remodeling+and+preserves+diastolic+function+in+diabetic+heart&amp;rft.jtitle=Hypertens.+Res.&amp;rft.aulast=Tsutsui+H%2C+Matsushima+S%2C+Kinugawa+S%2C+%27%27et+al%27%27&amp;rft.au=Tsutsui+H%2C+Matsushima+S%2C+Kinugawa+S%2C+%27%27et+al%27%27&amp;rft.date=May+2007&amp;rft.volume=30&amp;rft.issue=5&amp;rft.pages=439%E2%80%9349&amp;rft_id=info:doi/10.1291%2Fhypres.30.439&amp;rft_id=info:pmid/17587756&amp;rft_id=http%3A%2F%2Fjoi.jlc.jst.go.jp%2FJST.JSTAGE%2Fhypres%2F30.439%3Ffrom%3DPubMed&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKrug_AW.2C_Grossmann_C.2C_Schuster_C.2C_.27.27et_al.27.272003">Krug AW, Grossmann C, Schuster C, <i>et al</i> (October 2003). "Aldosterone stimulates epidermal growth factor receptor expression". <i>J. Biol. Chem.</i> <b>278</b> (44): 43060–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1074%2Fjbc.M308134200" class="external text" title="http://dx.doi.org/10.1074%2Fjbc.M308134200" rel="nofollow">10.1074/jbc.M308134200</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12939263" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12939263">PMID 12939263</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Aldosterone+stimulates+epidermal+growth+factor+receptor+expression&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.aulast=Krug+AW%2C+Grossmann+C%2C+Schuster+C%2C+%27%27et+al%27%27&amp;rft.au=Krug+AW%2C+Grossmann+C%2C+Schuster+C%2C+%27%27et+al%27%27&amp;rft.date=October+2003&amp;rft.volume=278&amp;rft.issue=44&amp;rft.pages=43060%E2%80%936&amp;rft_id=info:doi/10.1074%2Fjbc.M308134200&amp;rft_id=info:pmid/12939263&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <i><a href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=919601204" class="external text" title="http://www.gpnotebook.co.uk/simplepage.cfm?ID=919601204" rel="nofollow">systemic pathophysiology in heart failure</a></i> at <a href="/wiki/GPnotebook" title="GPnotebook">GPnotebook</a></li>
<li id="cite_note-pmid18290826-27"><b><a href="#cite_ref-pmid18290826_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFEwald_B.2C_Ewald_D.2C_Thakkinstian_A.2C_Attia_J2008">Ewald B, Ewald D, Thakkinstian A, Attia J (2008). "<a href="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01454.x" class="external text" title="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01454.x" rel="nofollow">Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction</a>". <i>Intern Med J</i> <b>38</b> (2): 101–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1445-5994.2007.01454.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1445-5994.2007.01454.x" rel="nofollow">10.1111/j.1445-5994.2007.01454.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18290826" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18290826">PMID 18290826</a><span class="printonly">. <a href="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01454.x" class="external free" title="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01454.x" rel="nofollow">http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01454.x</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Meta-analysis+of+B+type+natriuretic+peptide+and+N-terminal+pro+B+natriuretic+peptide+in+the+diagnosis+of+clinical+heart+failure+and+population+screening+for+left+ventricular+systolic+dysfunction&amp;rft.jtitle=Intern+Med+J&amp;rft.aulast=Ewald+B%2C+Ewald+D%2C+Thakkinstian+A%2C+Attia+J&amp;rft.au=Ewald+B%2C+Ewald+D%2C+Thakkinstian+A%2C+Attia+J&amp;rft.date=2008&amp;rft.volume=38&amp;rft.issue=2&amp;rft.pages=101%E2%80%9313&amp;rft_id=info:doi/10.1111%2Fj.1445-5994.2007.01454.x&amp;rft_id=info:pmid/18290826&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1111%2Fj.1445-5994.2007.01454.x&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Smith-28">^ <a href="#cite_ref-Smith_28-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Smith_28-1" title=""><sup><i><b>b</b></i></sup></a> Smith A, Aylward P, Campbell T, et al. Therapeutic Guidelines: Cardiovascular, 4th edition. North Melbourne: Therapeutic Guidelines; 2003. ISSN 1327-9513</li>
<li id="cite_note-pmidpending-29"><b><a href="#cite_ref-pmidpending_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChaudhry_SI_et_al2007">Chaudhry SI et al (2007). "Patterns of Weight Change Preceding Hospitalization for Heart Failure". <i>Circulation</i> <b>116</b>: 1549. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.107.690768" class="external text" title="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.107.690768" rel="nofollow">10.1161/CIRCULATIONAHA.107.690768</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17846286" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17846286">PMID 17846286</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Patterns+of+Weight+Change+Preceding+Hospitalization+for+Heart+Failure&amp;rft.jtitle=Circulation&amp;rft.aulast=Chaudhry+SI+et+al&amp;rft.au=Chaudhry+SI+et+al&amp;rft.date=2007&amp;rft.volume=116&amp;rft.pages=1549&amp;rft_id=info:doi/10.1161%2FCIRCULATIONAHA.107.690768&amp;rft_id=info:pmid/17846286&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> Jackson S, Bereznicki L, Peterson G. Under-use of ACE-inhibitor and β-blocker therapies in congestive cardiac failure. Australian Pharmacist 2005;24(12):936.</li>
<li id="cite_note-Packer-1989-31"><b><a href="#cite_ref-Packer-1989_31-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPacker_M1989">Packer M (1989). "Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure". <i>Am. J. Cardiol.</i> <b>63</b> (2): 41A–45A. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0002-9149%2889%2990392-5" class="external text" title="http://dx.doi.org/10.1016%2F0002-9149%2889%2990392-5" rel="nofollow">10.1016/0002-9149(89)90392-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2642629" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2642629">PMID 2642629</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+phosphodiesterase+inhibitors+on+survival+of+patients+with+chronic+congestive+heart+failure&amp;rft.jtitle=Am.+J.+Cardiol.&amp;rft.aulast=Packer+M&amp;rft.au=Packer+M&amp;rft.date=1989&amp;rft.volume=63&amp;rft.issue=2&amp;rft.pages=41A%E2%80%9345A&amp;rft_id=info:doi/10.1016%2F0002-9149%2889%2990392-5&amp;rft_id=info:pmid/2642629&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Packer-1991-32"><b><a href="#cite_ref-Packer-1991_32-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPacker_M.2C_Carver_JR.2C_Rodeheffer_RJ.2C_.27.27et_al.27.271991">Packer M, Carver JR, Rodeheffer RJ, <i>et al</i> (1991). "Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group". <i>N. Engl. J. Med.</i> <b>325</b> (21): 1468–75. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1944425" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1944425">PMID 1944425</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+oral+milrinone+on+mortality+in+severe+chronic+heart+failure.+The+PROMISE+Study+Research+Group&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Packer+M%2C+Carver+JR%2C+Rodeheffer+RJ%2C+%27%27et+al%27%27&amp;rft.au=Packer+M%2C+Carver+JR%2C+Rodeheffer+RJ%2C+%27%27et+al%27%27&amp;rft.date=1991&amp;rft.volume=325&amp;rft.issue=21&amp;rft.pages=1468%E2%80%9375&amp;rft_id=info:pmid/1944425&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Krum-2001-33"><b><a href="#cite_ref-Krum-2001_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKrum_H.2C_National_Heart_Foundation_of_Australia_and_Cardiac_Society_of_Australia_.26_New_Zealand_Chronic_Heart_Failure_Clinical_Practice_Guidelines_Writing_Panel.2001">Krum H, National Heart Foundation of Australia and Cardiac Society of Australia &amp; New Zealand Chronic Heart Failure Clinical Practice Guidelines Writing Panel. (2001). "Guidelines for management of patients with chronic heart failure in Australia". <i>Med J Aust</i> <b>174</b> (9): 459–66. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11386592" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11386592">PMID 11386592</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Guidelines+for+management+of+patients+with+chronic+heart+failure+in+Australia&amp;rft.jtitle=Med+J+Aust&amp;rft.aulast=Krum+H%2C+National+Heart+Foundation+of+Australia+and+Cardiac+Society+of+Australia+%26+New+Zealand+Chronic+Heart+Failure+Clinical+Practice+Guidelines+Writing+Panel.&amp;rft.au=Krum+H%2C+National+Heart+Foundation+of+Australia+and+Cardiac+Society+of+Australia+%26+New+Zealand+Chronic+Heart+Failure+Clinical+Practice+Guidelines+Writing+Panel.&amp;rft.date=2001&amp;rft.volume=174&amp;rft.issue=9&amp;rft.pages=459%E2%80%9366&amp;rft_id=info:pmid/11386592&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-NICECG5-34">^ <a href="#cite_ref-NICECG5_34-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NICECG5_34-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NICECG5_34-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NICECG5_34-3" title=""><sup><i><b>d</b></i></sup></a> National Institute for Clinical Excellence. Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. Clinical Guideline 5. London: National Institute for Clinical Excellence; 2003 Jul. Available from: <a href="http://www.nice.org.uk/pdf/CG5NICEguideline.pdf" class="external text" title="http://www.nice.org.uk/pdf/CG5NICEguideline.pdf" rel="nofollow">www.nice.org.uk/pdf/CG5NICEguideline.pdf</a></li>
<li id="cite_note-Granger-2003-35"><b><a href="#cite_ref-Granger-2003_35-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGranger_CB.2C_McMurray_JJ.2C_Yusuf_S.2C_Held_P.2C_Michelson_EL.2C_Olofsson_B.2C_Ostergren_J.2C_Pfeffer_MA.2C_Swedberg_K.3B_CHARM_Investigators_and_Committees.2003">Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. (2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial". <i>Lancet</i> <b>362</b> (9386): 772–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2803%2914284-5" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2803%2914284-5" rel="nofollow">10.1016/S0140-6736(03)14284-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/13678870" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/13678870">PMID 13678870</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+candesartan+in+patients+with+chronic+heart+failure+and+reduced+left-ventricular+systolic+function+intolerant+to+angiotensin-converting-enzyme+inhibitors%3A+the+CHARM-Alternative+trial&amp;rft.jtitle=Lancet&amp;rft.aulast=Granger+CB%2C+McMurray+JJ%2C+Yusuf+S%2C+Held+P%2C+Michelson+EL%2C+Olofsson+B%2C+Ostergren+J%2C+Pfeffer+MA%2C+Swedberg+K%3B+CHARM+Investigators+and+Committees.&amp;rft.au=Granger+CB%2C+McMurray+JJ%2C+Yusuf+S%2C+Held+P%2C+Michelson+EL%2C+Olofsson+B%2C+Ostergren+J%2C+Pfeffer+MA%2C+Swedberg+K%3B+CHARM+Investigators+and+Committees.&amp;rft.date=2003&amp;rft.volume=362&amp;rft.issue=9386&amp;rft.pages=772%E2%80%936&amp;rft_id=info:doi/10.1016%2FS0140-6736%2803%2914284-5&amp;rft_id=info:pmid/13678870&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Pfeffer-2003-36"><b><a href="#cite_ref-Pfeffer-2003_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPfeffer_MA.2C_Swedberg_K.2C_Granger_CB.2C_Held_P.2C_McMurray_JJ.2C_Michelson_EL.2C_Olofsson_B.2C_Ostergren_J.2C_Yusuf_S.2C_Pocock_S.3B_CHARM_Investigators_and_Committees.2003">Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme". <i>Lancet</i> <b>362</b> (9386): 759–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2803%2914282-1" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2803%2914282-1" rel="nofollow">10.1016/S0140-6736(03)14282-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/13678868" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/13678868">PMID 13678868</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+candesartan+on+mortality+and+morbidity+in+patients+with+chronic+heart+failure%3A+the+CHARM-Overall+programme&amp;rft.jtitle=Lancet&amp;rft.aulast=Pfeffer+MA%2C+Swedberg+K%2C+Granger+CB%2C+Held+P%2C+McMurray+JJ%2C+Michelson+EL%2C+Olofsson+B%2C+Ostergren+J%2C+Yusuf+S%2C+Pocock+S%3B+CHARM+Investigators+and+Committees.&amp;rft.au=Pfeffer+MA%2C+Swedberg+K%2C+Granger+CB%2C+Held+P%2C+McMurray+JJ%2C+Michelson+EL%2C+Olofsson+B%2C+Ostergren+J%2C+Yusuf+S%2C+Pocock+S%3B+CHARM+Investigators+and+Committees.&amp;rft.date=2003&amp;rft.volume=362&amp;rft.issue=9386&amp;rft.pages=759%E2%80%9366&amp;rft_id=info:doi/10.1016%2FS0140-6736%2803%2914282-1&amp;rft_id=info:pmid/13678868&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHaji_SA.2C_Movahed_A2000">Haji SA, Movahed A (2000). "Update on digoxin therapy in congestive heart failure". <i>American family physician</i> <b>62</b> (2): 409–16. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10929703" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10929703">PMID 10929703</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Update+on+digoxin+therapy+in+congestive+heart+failure&amp;rft.jtitle=American+family+physician&amp;rft.aulast=Haji+SA%2C+Movahed+A&amp;rft.au=Haji+SA%2C+Movahed+A&amp;rft.date=2000&amp;rft.volume=62&amp;rft.issue=2&amp;rft.pages=409%E2%80%9316&amp;rft_id=info:pmid/10929703&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Exner-2001-38"><b><a href="#cite_ref-Exner-2001_38-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFExner_DV.2C_Dries_DL.2C_Domanski_MJ.2C_Cohn_JN2001">Exner DV, Dries DL, Domanski MJ, Cohn JN (2001). "Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction". <i>N Engl J Med.</i> <b>344</b> (18): 1351–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM200105033441802" class="external text" title="http://dx.doi.org/10.1056%2FNEJM200105033441802" rel="nofollow">10.1056/NEJM200105033441802</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11333991" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11333991">PMID 11333991</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lesser+response+to+angiotensin-converting-enzyme+inhibitor+therapy+in+black+as+compared+with+white+patients+with+left+ventricular+dysfunction&amp;rft.jtitle=N+Engl+J+Med.&amp;rft.aulast=Exner+DV%2C+Dries+DL%2C+Domanski+MJ%2C+Cohn+JN&amp;rft.au=Exner+DV%2C+Dries+DL%2C+Domanski+MJ%2C+Cohn+JN&amp;rft.date=2001&amp;rft.volume=344&amp;rft.issue=18&amp;rft.pages=1351%E2%80%937&amp;rft_id=info:doi/10.1056%2FNEJM200105033441802&amp;rft_id=info:pmid/11333991&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Taylor-2004-39"><b><a href="#cite_ref-Taylor-2004_39-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTaylor_AL.2C_Ziesche_S.2C_Yancy_C.2C_Carson_P.2C_D.27Agostino_R_Jr.2C_Ferdinand_K.2C_Taylor_M.2C_Adams_K.2C_Sabolinski_M.2C_Worcel_M.2C_Cohn_JN.3B_African-American_Heart_Failure_Trial_Investigators.2004">Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. (2004). "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure". <i>N Engl J Med</i> <b>351</b> (20): 2049–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa042934" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa042934" rel="nofollow">10.1056/NEJMoa042934</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15533851" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15533851">PMID 15533851</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Combination+of+isosorbide+dinitrate+and+hydralazine+in+blacks+with+heart+failure&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Taylor+AL%2C+Ziesche+S%2C+Yancy+C%2C+Carson+P%2C+D%27Agostino+R+Jr%2C+Ferdinand+K%2C+Taylor+M%2C+Adams+K%2C+Sabolinski+M%2C+Worcel+M%2C+Cohn+JN%3B+African-American+Heart+Failure+Trial+Investigators.&amp;rft.au=Taylor+AL%2C+Ziesche+S%2C+Yancy+C%2C+Carson+P%2C+D%27Agostino+R+Jr%2C+Ferdinand+K%2C+Taylor+M%2C+Adams+K%2C+Sabolinski+M%2C+Worcel+M%2C+Cohn+JN%3B+African-American+Heart+Failure+Trial+Investigators.&amp;rft.date=2004&amp;rft.volume=351&amp;rft.issue=20&amp;rft.pages=2049%E2%80%9357&amp;rft_id=info:doi/10.1056%2FNEJMoa042934&amp;rft_id=info:pmid/15533851&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Pitt-1999-40"><b><a href="#cite_ref-Pitt-1999_40-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPitt_B.2C_Zannad_F.2C_Remme_W.2C_Cody_R.2C_Castaigne_A.2C_Perez_A.2C_Palensky_J.2C_Wittes_J1999">Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999). "The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure". <i>N Engl J Med.</i> <b>341</b> (10): 709–717. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM199909023411001" class="external text" title="http://dx.doi.org/10.1056%2FNEJM199909023411001" rel="nofollow">10.1056/NEJM199909023411001</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10471456" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10471456">PMID 10471456</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+Effect+of+Spironolactone+on+Morbidity+and+Mortality+in+Patients+with+Severe+Heart+Failure&amp;rft.jtitle=N+Engl+J+Med.&amp;rft.aulast=Pitt+B%2C+Zannad+F%2C+Remme+W%2C+Cody+R%2C+Castaigne+A%2C+Perez+A%2C+Palensky+J%2C+Wittes+J&amp;rft.au=Pitt+B%2C+Zannad+F%2C+Remme+W%2C+Cody+R%2C+Castaigne+A%2C+Perez+A%2C+Palensky+J%2C+Wittes+J&amp;rft.date=1999&amp;rft.volume=341&amp;rft.issue=10&amp;rft.pages=709%E2%80%93717&amp;rft_id=info:doi/10.1056%2FNEJM199909023411001&amp;rft_id=info:pmid/10471456&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Pitt-2001-41"><b><a href="#cite_ref-Pitt-2001_41-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPitt_B.2C_Williams_G.2C_Remme_W.2C_Martinez_F.2C_Lopez-Sendon_J.2C_Zannad_F.2C_Neaton_J.2C_Roniker_B.2C_Hurley_S.2C_Burns_D.2C_Bittman_R.2C_Kleiman_J.2001">Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J. (2001). "The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study". <i>Cardiovasc Drugs Ther</i> <b>15</b> (1): 79–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1023%2FA%3A1011119003788" class="external text" title="http://dx.doi.org/10.1023%2FA%3A1011119003788" rel="nofollow">10.1023/A:1011119003788</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11504167" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11504167">PMID 11504167</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+EPHESUS+trial%3A+eplerenone+in+patients+with+heart+failure+due+to+systolic+dysfunction+complicating+acute+myocardial+infarction.+Eplerenone+Post-AMI+Heart+Failure+Efficacy+and+Survival+Study&amp;rft.jtitle=Cardiovasc+Drugs+Ther&amp;rft.aulast=Pitt+B%2C+Williams+G%2C+Remme+W%2C+Martinez+F%2C+Lopez-Sendon+J%2C+Zannad+F%2C+Neaton+J%2C+Roniker+B%2C+Hurley+S%2C+Burns+D%2C+Bittman+R%2C+Kleiman+J.&amp;rft.au=Pitt+B%2C+Williams+G%2C+Remme+W%2C+Martinez+F%2C+Lopez-Sendon+J%2C+Zannad+F%2C+Neaton+J%2C+Roniker+B%2C+Hurley+S%2C+Burns+D%2C+Bittman+R%2C+Kleiman+J.&amp;rft.date=2001&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=79%E2%80%9387&amp;rft_id=info:doi/10.1023%2FA%3A1011119003788&amp;rft_id=info:pmid/11504167&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Gheorghiade-2007-42"><b><a href="#cite_ref-Gheorghiade-2007_42-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGheorghiade_M.2C_Konstam_MA.2C_Burnett_JC_Jr.2C_Grinfeld_L.2C_Maggioni_AP.2C_Swedberg_K.2C_Udelson_JE.2C_Zannad_F.2C_Cook_T.2C_Ouyang_J.2C_Zimmer_C.2C_Orlandi_C.3B_Efficacy_of_Vasopressin_Antagonism_in_Heart_Failure_Outcome_Study_With_Tolvaptan_.28EVEREST.29_Investigators.2007">Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. (2007). "Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials". <i>JAMA</i> <b>297</b> (12): 1332–1343. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.297.12.1332" class="external text" title="http://dx.doi.org/10.1001%2Fjama.297.12.1332" rel="nofollow">10.1001/jama.297.12.1332</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17384438" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17384438">PMID 17384438</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Short-term+clinical+effects+of+tolvaptan%2C+an+oral+vasopressin+antagonist%2C+in+patients+hospitalized+for+heart+failure%3A+the+EVEREST+Clinical+Status+Trials&amp;rft.jtitle=JAMA&amp;rft.aulast=Gheorghiade+M%2C+Konstam+MA%2C+Burnett+JC+Jr%2C+Grinfeld+L%2C+Maggioni+AP%2C+Swedberg+K%2C+Udelson+JE%2C+Zannad+F%2C+Cook+T%2C+Ouyang+J%2C+Zimmer+C%2C+Orlandi+C%3B+Efficacy+of+Vasopressin+Antagonism+in+Heart+Failure+Outcome+Study+With+Tolvaptan+%28EVEREST%29+Investigators.&amp;rft.au=Gheorghiade+M%2C+Konstam+MA%2C+Burnett+JC+Jr%2C+Grinfeld+L%2C+Maggioni+AP%2C+Swedberg+K%2C+Udelson+JE%2C+Zannad+F%2C+Cook+T%2C+Ouyang+J%2C+Zimmer+C%2C+Orlandi+C%3B+Efficacy+of+Vasopressin+Antagonism+in+Heart+Failure+Outcome+Study+With+Tolvaptan+%28EVEREST%29+Investigators.&amp;rft.date=2007&amp;rft.volume=297&amp;rft.issue=12&amp;rft.pages=1332%E2%80%931343&amp;rft_id=info:doi/10.1001%2Fjama.297.12.1332&amp;rft_id=info:pmid/17384438&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Konstam-2007-43"><b><a href="#cite_ref-Konstam-2007_43-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKonstam_MA.2C_Gheorghiade_M.2C_Burnett_JC_Jr.2C_Grinfeld_L.2C_Maggioni_AP.2C_Swedberg_K.2C_Udelson_JE.2C_Zannad_F.2C_Cook_T.2C_Ouyang_J.2C_Zimmer_C.2C_Orlandi_C.3B_Efficacy_of_Vasopressin_Antagonism_in_Heart_Failure_Outcome_Study_With_Tolvaptan_.28EVEREST.29_Investigators.2007">Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. (2007). "Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial". <i>JAMA</i> <b>297</b> (12): 1319–1331. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.297.12.1319" class="external text" title="http://dx.doi.org/10.1001%2Fjama.297.12.1319" rel="nofollow">10.1001/jama.297.12.1319</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17384437" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17384437">PMID 17384437</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+oral+tolvaptan+in+patients+hospitalized+for+worsening+heart+failure%3A+the+EVEREST+Outcome+Trial&amp;rft.jtitle=JAMA&amp;rft.aulast=Konstam+MA%2C+Gheorghiade+M%2C+Burnett+JC+Jr%2C+Grinfeld+L%2C+Maggioni+AP%2C+Swedberg+K%2C+Udelson+JE%2C+Zannad+F%2C+Cook+T%2C+Ouyang+J%2C+Zimmer+C%2C+Orlandi+C%3B+Efficacy+of+Vasopressin+Antagonism+in+Heart+Failure+Outcome+Study+With+Tolvaptan+%28EVEREST%29+Investigators.&amp;rft.au=Konstam+MA%2C+Gheorghiade+M%2C+Burnett+JC+Jr%2C+Grinfeld+L%2C+Maggioni+AP%2C+Swedberg+K%2C+Udelson+JE%2C+Zannad+F%2C+Cook+T%2C+Ouyang+J%2C+Zimmer+C%2C+Orlandi+C%3B+Efficacy+of+Vasopressin+Antagonism+in+Heart+Failure+Outcome+Study+With+Tolvaptan+%28EVEREST%29+Investigators.&amp;rft.date=2007&amp;rft.volume=297&amp;rft.issue=12&amp;rft.pages=1319%E2%80%931331&amp;rft_id=info:doi/10.1001%2Fjama.297.12.1319&amp;rft_id=info:pmid/17384437&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Bristow-2004-44"><b><a href="#cite_ref-Bristow-2004_44-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBristow_MR.2C_Saxon_LA.2C_Boehmer_J.2C_Krueger_S.2C_Kass_DA.2C_De_Marco_T.2C_Carson_P.2C_DiCarlo_L.2C_DeMets_D.2C_White_BG.2C_DeVries_DW.2C_Feldman_AM.3B_Comparison_of_Medical_Therapy.2C_Pacing.2C_and_Defibrillation_in_Heart_Failure_.28COMPANION.29_Investigators.2004">Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. (2004). "Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure". <i>N Engl J Med</i> <b>350</b> (21): 2140–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa032423" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa032423" rel="nofollow">10.1056/NEJMoa032423</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15152059" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15152059">PMID 15152059</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cardiac-resynchronization+therapy+with+or+without+an+implantable+defibrillator+in+advanced+chronic+heart+failure&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Bristow+MR%2C+Saxon+LA%2C+Boehmer+J%2C+Krueger+S%2C+Kass+DA%2C+De+Marco+T%2C+Carson+P%2C+DiCarlo+L%2C+DeMets+D%2C+White+BG%2C+DeVries+DW%2C+Feldman+AM%3B+Comparison+of+Medical+Therapy%2C+Pacing%2C+and+Defibrillation+in+Heart+Failure+%28COMPANION%29+Investigators.&amp;rft.au=Bristow+MR%2C+Saxon+LA%2C+Boehmer+J%2C+Krueger+S%2C+Kass+DA%2C+De+Marco+T%2C+Carson+P%2C+DiCarlo+L%2C+DeMets+D%2C+White+BG%2C+DeVries+DW%2C+Feldman+AM%3B+Comparison+of+Medical+Therapy%2C+Pacing%2C+and+Defibrillation+in+Heart+Failure+%28COMPANION%29+Investigators.&amp;rft.date=2004&amp;rft.volume=350&amp;rft.issue=21&amp;rft.pages=2140%E2%80%9350&amp;rft_id=info:doi/10.1056%2FNEJMoa032423&amp;rft_id=info:pmid/15152059&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Cleland-2005-45"><b><a href="#cite_ref-Cleland-2005_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCleland_JG.2C_Daubert_JC.2C_Erdmann_E.2C_Freemantle_N.2C_Gras_D.2C_Kappenberger_L.2C_Tavazzi_L.3B_Cardiac_Resynchronization-Heart_Failure_.28CARE-HF.29_Study_Investigators.2005">Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. (2005). "The effect of cardiac resynchronization on morbidity and mortality in heart failure". <i>N Engl J Med</i> <b>352</b> (15): 1539–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa050496" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa050496" rel="nofollow">10.1056/NEJMoa050496</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15753115" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15753115">PMID 15753115</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effect+of+cardiac+resynchronization+on+morbidity+and+mortality+in+heart+failure&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Cleland+JG%2C+Daubert+JC%2C+Erdmann+E%2C+Freemantle+N%2C+Gras+D%2C+Kappenberger+L%2C+Tavazzi+L%3B+Cardiac+Resynchronization-Heart+Failure+%28CARE-HF%29+Study+Investigators.&amp;rft.au=Cleland+JG%2C+Daubert+JC%2C+Erdmann+E%2C+Freemantle+N%2C+Gras+D%2C+Kappenberger+L%2C+Tavazzi+L%3B+Cardiac+Resynchronization-Heart+Failure+%28CARE-HF%29+Study+Investigators.&amp;rft.date=2005&amp;rft.volume=352&amp;rft.issue=15&amp;rft.pages=1539%E2%80%9349&amp;rft_id=info:doi/10.1056%2FNEJMoa050496&amp;rft_id=info:pmid/15753115&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Bardy-2005-46"><b><a href="#cite_ref-Bardy-2005_46-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBardy_GH.2C_Lee_KL.2C_Mark_DB.2C_Poole_JE.2C_Packer_DL.2C_Boineau_R.2C_Domanski_M.2C_Troutman_C.2C_Anderson_J.2C_Johnson_G.2C_McNulty_SE.2C_Clapp-Channing_N.2C_Davidson-Ray_LD.2C_Fraulo_ES.2C_Fishbein_DP.2C_Luceri_RM.2C_Ip_JH.3B_Sudden_Cardiac_Death_in_Heart_Failure_Trial_.28SCD-HeFT.29_Investigators.2005">Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. (2005). "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure". <i>N Engl J Med</i> <b>352</b> (3): 225–237. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa043399" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa043399" rel="nofollow">10.1056/NEJMoa043399</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15659722" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15659722">PMID 15659722</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Amiodarone+or+an+implantable+cardioverter-defibrillator+for+congestive+heart+failure&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Bardy+GH%2C+Lee+KL%2C+Mark+DB%2C+Poole+JE%2C+Packer+DL%2C+Boineau+R%2C+Domanski+M%2C+Troutman+C%2C+Anderson+J%2C+Johnson+G%2C+McNulty+SE%2C+Clapp-Channing+N%2C+Davidson-Ray+LD%2C+Fraulo+ES%2C+Fishbein+DP%2C+Luceri+RM%2C+Ip+JH%3B+Sudden+Cardiac+Death+in+Heart+Failure+Trial+%28SCD-HeFT%29+Investigators.&amp;rft.au=Bardy+GH%2C+Lee+KL%2C+Mark+DB%2C+Poole+JE%2C+Packer+DL%2C+Boineau+R%2C+Domanski+M%2C+Troutman+C%2C+Anderson+J%2C+Johnson+G%2C+McNulty+SE%2C+Clapp-Channing+N%2C+Davidson-Ray+LD%2C+Fraulo+ES%2C+Fishbein+DP%2C+Luceri+RM%2C+Ip+JH%3B+Sudden+Cardiac+Death+in+Heart+Failure+Trial+%28SCD-HeFT%29+Investigators.&amp;rft.date=2005&amp;rft.volume=352&amp;rft.issue=3&amp;rft.pages=225%E2%80%93237&amp;rft_id=info:doi/10.1056%2FNEJMoa043399&amp;rft_id=info:pmid/15659722&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11907286-47"><b><a href="#cite_ref-pmid11907286_47-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMoss_AJ.2C_Zareba_W.2C_Hall_WJ.2C_.27.27et_al.27.272002">Moss AJ, Zareba W, Hall WJ, <i>et al</i> (March 2002). "<a href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11907286&amp;promo=ONFLNS19" class="external text" title="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11907286&amp;promo=ONFLNS19" rel="nofollow">Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction</a>". <i>N. Engl. J. Med.</i> <b>346</b> (12): 877–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa013474" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa013474" rel="nofollow">10.1056/NEJMoa013474</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11907286" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11907286">PMID 11907286</a><span class="printonly">. <a href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11907286&amp;promo=ONFLNS19" class="external free" title="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11907286&amp;promo=ONFLNS19" rel="nofollow">http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11907286&amp;promo=ONFLNS19</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prophylactic+implantation+of+a+defibrillator+in+patients+with+myocardial+infarction+and+reduced+ejection+fraction&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Moss+AJ%2C+Zareba+W%2C+Hall+WJ%2C+%27%27et+al%27%27&amp;rft.au=Moss+AJ%2C+Zareba+W%2C+Hall+WJ%2C+%27%27et+al%27%27&amp;rft.date=March+2002&amp;rft.volume=346&amp;rft.issue=12&amp;rft.pages=877%E2%80%9383&amp;rft_id=info:doi/10.1056%2FNEJMoa013474&amp;rft_id=info:pmid/11907286&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D11907286%26promo%3DONFLNS19&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18768943-48"><b><a href="#cite_ref-pmid18768943_48-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMark_DB.2C_Anstrom_KJ.2C_Sun_JL.2C_Clapp-Channing_NE.2C_Tsiatis_AA.2C_Davidson-Ray_L.2C_Lee_KL.2C_Bardy_GH.3B_Sudden_Cardiac_Death_in_Heart_Failure_Trial_Investigators2008">Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH; Sudden Cardiac Death in Heart Failure Trial Investigators (September 2008). "<a href="http://content.nejm.org/cgi/content/abstract/359/10/999" class="external text" title="http://content.nejm.org/cgi/content/abstract/359/10/999" rel="nofollow">Quality of life with defibrillator therapy or amiodarone in heart failure</a>". <i>N. Engl. J. Med.</i> <b>359</b> (10): 999–1008. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa0706719" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa0706719" rel="nofollow">10.1056/NEJMoa0706719</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18768943" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18768943">PMID 18768943</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/abstract/359/10/999" class="external free" title="http://content.nejm.org/cgi/content/abstract/359/10/999" rel="nofollow">http://content.nejm.org/cgi/content/abstract/359/10/999</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Quality+of+life+with+defibrillator+therapy+or+amiodarone+in+heart+failure&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Mark+DB%2C+Anstrom+KJ%2C+Sun+JL%2C+Clapp-Channing+NE%2C+Tsiatis+AA%2C+Davidson-Ray+L%2C+Lee+KL%2C+Bardy+GH%3B+Sudden+Cardiac+Death+in+Heart+Failure+Trial+Investigators&amp;rft.au=Mark+DB%2C+Anstrom+KJ%2C+Sun+JL%2C+Clapp-Channing+NE%2C+Tsiatis+AA%2C+Davidson-Ray+L%2C+Lee+KL%2C+Bardy+GH%3B+Sudden+Cardiac+Death+in+Heart+Failure+Trial+Investigators&amp;rft.date=September+2008&amp;rft.volume=359&amp;rft.issue=10&amp;rft.pages=999%E2%80%931008&amp;rft_id=info:doi/10.1056%2FNEJMoa0706719&amp;rft_id=info:pmid/18768943&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2F359%2F10%2F999&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18768944-49"><b><a href="#cite_ref-pmid18768944_49-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPoole_JE.2C_Johnson_GW.2C_Hellkamp_AS.2C_Anderson_J.2C_Callans_DJ.2C_Raitt_MH.2C_Reddy_RK.2C_Marchlinski_FE.2C_Yee_R.2C_Guarnieri_T.2C_Talajic_M.2C_Wilber_DJ.2C_Fishbein_DP.2C_Packer_DL.2C_Mark_DB.2C_Lee_KL.2C_Bardy_GH.3B_Sudden_Cardiac_Death_in_Heart_Failure_Trial_Investigators2008">Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH; Sudden Cardiac Death in Heart Failure Trial Investigators (September 2008). "<a href="http://content.nejm.org/cgi/content/abstract/359/10/1009" class="external text" title="http://content.nejm.org/cgi/content/abstract/359/10/1009" rel="nofollow">Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure</a>". <i>N. Engl. J. Med.</i> <b>359</b> (10): 1009–1017. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa071098" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa071098" rel="nofollow">10.1056/NEJMoa071098</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18768944" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18768944">PMID 18768944</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/abstract/359/10/1009" class="external free" title="http://content.nejm.org/cgi/content/abstract/359/10/1009" rel="nofollow">http://content.nejm.org/cgi/content/abstract/359/10/1009</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prognostic+Importance+of+Defibrillator+Shocks+in+Patients+with+Heart+Failure&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Poole+JE%2C+Johnson+GW%2C+Hellkamp+AS%2C+Anderson+J%2C+Callans+DJ%2C+Raitt+MH%2C+Reddy+RK%2C+Marchlinski+FE%2C+Yee+R%2C+Guarnieri+T%2C+Talajic+M%2C+Wilber+DJ%2C+Fishbein+DP%2C+Packer+DL%2C+Mark+DB%2C+Lee+KL%2C+Bardy+GH%3B+Sudden+Cardiac+Death+in+Heart+Failure+Trial+Investigators&amp;rft.au=Poole+JE%2C+Johnson+GW%2C+Hellkamp+AS%2C+Anderson+J%2C+Callans+DJ%2C+Raitt+MH%2C+Reddy+RK%2C+Marchlinski+FE%2C+Yee+R%2C+Guarnieri+T%2C+Talajic+M%2C+Wilber+DJ%2C+Fishbein+DP%2C+Packer+DL%2C+Mark+DB%2C+Lee+KL%2C+Bardy+GH%3B+Sudden+Cardiac+Death+in+Heart+Failure+Trial+Investigators&amp;rft.date=September+2008&amp;rft.volume=359&amp;rft.issue=10&amp;rft.pages=1009%E2%80%931017&amp;rft_id=info:doi/10.1056%2FNEJMoa071098&amp;rft_id=info:pmid/18768944&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2F359%2F10%2F1009&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16207849-50"><b><a href="#cite_ref-pmid16207849_50-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSanders_GD.2C_Hlatky_MA.2C_Owens_DK2005">Sanders GD, Hlatky MA, Owens DK (October 2005). "<a href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=16207849&amp;promo=ONFLNS19" class="external text" title="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=16207849&amp;promo=ONFLNS19" rel="nofollow">Cost-effectiveness of implantable cardioverter-defibrillators</a>". <i>N. Engl. J. Med.</i> <b>353</b> (14): 1471–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMsa051989" class="external text" title="http://dx.doi.org/10.1056%2FNEJMsa051989" rel="nofollow">10.1056/NEJMsa051989</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16207849" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16207849">PMID 16207849</a><span class="printonly">. <a href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=16207849&amp;promo=ONFLNS19" class="external free" title="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=16207849&amp;promo=ONFLNS19" rel="nofollow">http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=16207849&amp;promo=ONFLNS19</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cost-effectiveness+of+implantable+cardioverter-defibrillators&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Sanders+GD%2C+Hlatky+MA%2C+Owens+DK&amp;rft.au=Sanders+GD%2C+Hlatky+MA%2C+Owens+DK&amp;rft.date=October+2005&amp;rft.volume=353&amp;rft.issue=14&amp;rft.pages=1471%E2%80%9380&amp;rft_id=info:doi/10.1056%2FNEJMsa051989&amp;rft_id=info:pmid/16207849&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D16207849%26promo%3DONFLNS19&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16087128-51">^ <a href="#cite_ref-pmid16087128_51-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16087128_51-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFT.C3.B8nnessen_T.2C_Knudsen_CW2005">Tønnessen T, Knudsen CW (August 2005). "Surgical left ventricular remodeling in heart failure". <i>Eur. J. Heart Fail.</i> <b>7</b> (5): 704–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ejheart.2005.07.005" class="external text" title="http://dx.doi.org/10.1016%2Fj.ejheart.2005.07.005" rel="nofollow">10.1016/j.ejheart.2005.07.005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16087128" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16087128">PMID 16087128</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Surgical+left+ventricular+remodeling+in+heart+failure&amp;rft.jtitle=Eur.+J.+Heart+Fail.&amp;rft.aulast=T%C3%B8nnessen+T%2C+Knudsen+CW&amp;rft.au=T%C3%B8nnessen+T%2C+Knudsen+CW&amp;rft.date=August+2005&amp;rft.volume=7&amp;rft.issue=5&amp;rft.pages=704%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.ejheart.2005.07.005&amp;rft_id=info:pmid/16087128&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid13538738-52"><b><a href="#cite_ref-pmid13538738_52-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCooley_DA.2C_Collins_HA.2C_Morris_GC.2C_Chapman_DW1958">Cooley DA, Collins HA, Morris GC, Chapman DW (May 1958). "Ventricular aneurysm after myocardial infarction; surgical excision with use of temporary cardiopulmonary bypass". <i>J Am Med Assoc</i> <b>167</b> (5): 557–60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/13538738" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/13538738">PMID 13538738</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ventricular+aneurysm+after+myocardial+infarction%3B+surgical+excision+with+use+of+temporary+cardiopulmonary+bypass&amp;rft.jtitle=J+Am+Med+Assoc&amp;rft.aulast=Cooley+DA%2C+Collins+HA%2C+Morris+GC%2C+Chapman+DW&amp;rft.au=Cooley+DA%2C+Collins+HA%2C+Morris+GC%2C+Chapman+DW&amp;rft.date=May+1958&amp;rft.volume=167&amp;rft.issue=5&amp;rft.pages=557%E2%80%9360&amp;rft_id=info:pmid/13538738&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11391036-53"><b><a href="#cite_ref-pmid11391036_53-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDor_V2001">Dor V (September 2001). "<a href="http://www.kluweronline.com/art.pdf?issn=1382-4147&amp;volume=6&amp;page=187" class="external text" title="http://www.kluweronline.com/art.pdf?issn=1382-4147&amp;volume=6&amp;page=187" rel="nofollow">The endoventricular circular patch plasty ("Dor procedure") in ischemic akinetic dilated ventricles</a>". <i>Heart Fail Rev</i> <b>6</b> (3): 187–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1023%2FA%3A1011477132227" class="external text" title="http://dx.doi.org/10.1023%2FA%3A1011477132227" rel="nofollow">10.1023/A:1011477132227</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11391036" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11391036">PMID 11391036</a><span class="printonly">. <a href="http://www.kluweronline.com/art.pdf?issn=1382-4147&amp;volume=6&amp;page=187" class="external free" title="http://www.kluweronline.com/art.pdf?issn=1382-4147&amp;volume=6&amp;page=187" rel="nofollow">http://www.kluweronline.com/art.pdf?issn=1382-4147&amp;volume=6&amp;page=187</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+endoventricular+circular+patch+plasty+%28%22Dor+procedure%22%29+in+ischemic+akinetic+dilated+ventricles&amp;rft.jtitle=Heart+Fail+Rev&amp;rft.aulast=Dor+V&amp;rft.au=Dor+V&amp;rft.date=September+2001&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=187%E2%80%9393&amp;rft_id=info:doi/10.1023%2FA%3A1011477132227&amp;rft_id=info:pmid/11391036&amp;rft_id=http%3A%2F%2Fwww.kluweronline.com%2Fart.pdf%3Fissn%3D1382-4147%26volume%3D6%26page%3D187&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15354107-54"><b><a href="#cite_ref-pmid15354107_54-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLundblad_R.2C_Abdelnoor_M.2C_Svennevig_JL2004">Lundblad R, Abdelnoor M, Svennevig JL (September 2004). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0022522304006427" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0022522304006427" rel="nofollow">Surgery for left ventricular aneurysm: early and late survival after simple linear repair and endoventricular patch plasty</a>". <i>J. Thorac. Cardiovasc. Surg.</i> <b>128</b> (3): 449–56. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jtcvs.2004.04.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.jtcvs.2004.04.017" rel="nofollow">10.1016/j.jtcvs.2004.04.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15354107" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15354107">PMID 15354107</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022522304006427" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0022522304006427" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0022522304006427</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Surgery+for+left+ventricular+aneurysm%3A+early+and+late+survival+after+simple+linear+repair+and+endoventricular+patch+plasty&amp;rft.jtitle=J.+Thorac.+Cardiovasc.+Surg.&amp;rft.aulast=Lundblad+R%2C+Abdelnoor+M%2C+Svennevig+JL&amp;rft.au=Lundblad+R%2C+Abdelnoor+M%2C+Svennevig+JL&amp;rft.date=September+2004&amp;rft.volume=128&amp;rft.issue=3&amp;rft.pages=449%E2%80%9356&amp;rft_id=info:doi/10.1016%2Fj.jtcvs.2004.04.017&amp;rft_id=info:pmid/15354107&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0022522304006427&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11279407-55"><b><a href="#cite_ref-pmid11279407_55-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMickleborough_LL.2C_Carson_S.2C_Ivanov_J2001">Mickleborough LL, Carson S, Ivanov J (April 2001). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)49811-4" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)49811-4" rel="nofollow">Repair of dyskinetic or akinetic left ventricular aneurysm: results obtained with a modified linear closure</a>". <i>J. Thorac. Cardiovasc. Surg.</i> <b>121</b> (4): 675–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1067%2Fmtc.2001.112633" class="external text" title="http://dx.doi.org/10.1067%2Fmtc.2001.112633" rel="nofollow">10.1067/mtc.2001.112633</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11279407" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11279407">PMID 11279407</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)49811-4" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)49811-4" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)49811-4</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Repair+of+dyskinetic+or+akinetic+left+ventricular+aneurysm%3A+results+obtained+with+a+modified+linear+closure&amp;rft.jtitle=J.+Thorac.+Cardiovasc.+Surg.&amp;rft.aulast=Mickleborough+LL%2C+Carson+S%2C+Ivanov+J&amp;rft.au=Mickleborough+LL%2C+Carson+S%2C+Ivanov+J&amp;rft.date=April+2001&amp;rft.volume=121&amp;rft.issue=4&amp;rft.pages=675%E2%80%9382&amp;rft_id=info:doi/10.1067%2Fmtc.2001.112633&amp;rft_id=info:pmid/11279407&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0022-5223%2801%2949811-4&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15464325-56"><b><a href="#cite_ref-pmid15464325_56-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAthanasuleas_CL.2C_Buckberg_GD.2C_Stanley_AW.2C_.27.27et_al.27.272004">Athanasuleas CL, Buckberg GD, Stanley AW, <i>et al</i> (October 2004). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(04)01443-3" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(04)01443-3" rel="nofollow">Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation</a>". <i>J. Am. Coll. Cardiol.</i> <b>44</b> (7): 1439–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jacc.2004.07.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.jacc.2004.07.017" rel="nofollow">10.1016/j.jacc.2004.07.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15464325" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15464325">PMID 15464325</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(04)01443-3" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(04)01443-3" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(04)01443-3</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Surgical+ventricular+restoration+in+the+treatment+of+congestive+heart+failure+due+to+post-infarction+ventricular+dilation&amp;rft.jtitle=J.+Am.+Coll.+Cardiol.&amp;rft.aulast=Athanasuleas+CL%2C+Buckberg+GD%2C+Stanley+AW%2C+%27%27et+al%27%27&amp;rft.au=Athanasuleas+CL%2C+Buckberg+GD%2C+Stanley+AW%2C+%27%27et+al%27%27&amp;rft.date=October+2004&amp;rft.volume=44&amp;rft.issue=7&amp;rft.pages=1439%E2%80%9345&amp;rft_id=info:doi/10.1016%2Fj.jacc.2004.07.017&amp;rft_id=info:pmid/15464325&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0735-1097%2804%2901443-3&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18023680-57"><b><a href="#cite_ref-pmid18023680_57-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVelazquez_EJ.2C_Lee_KL.2C_O.27Connor_CM.2C_.27.27et_al.27.272007">Velazquez EJ, Lee KL, O'Connor CM, <i>et al</i> (December 2007). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(07)01391-8" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(07)01391-8" rel="nofollow">The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial</a>". <i>J. Thorac. Cardiovasc. Surg.</i> <b>134</b> (6): 1540–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jtcvs.2007.05.069" class="external text" title="http://dx.doi.org/10.1016%2Fj.jtcvs.2007.05.069" rel="nofollow">10.1016/j.jtcvs.2007.05.069</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18023680" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18023680">PMID 18023680</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(07)01391-8" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(07)01391-8" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(07)01391-8</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+rationale+and+design+of+the+Surgical+Treatment+for+Ischemic+Heart+Failure+%28STICH%29+trial&amp;rft.jtitle=J.+Thorac.+Cardiovasc.+Surg.&amp;rft.aulast=Velazquez+EJ%2C+Lee+KL%2C+O%27Connor+CM%2C+%27%27et+al%27%27&amp;rft.au=Velazquez+EJ%2C+Lee+KL%2C+O%27Connor+CM%2C+%27%27et+al%27%27&amp;rft.date=December+2007&amp;rft.volume=134&amp;rft.issue=6&amp;rft.pages=1540%E2%80%937&amp;rft_id=info:doi/10.1016%2Fj.jtcvs.2007.05.069&amp;rft_id=info:pmid/18023680&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0022-5223%2807%2901391-8&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-58"><b><a href="#cite_ref-58" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.pbs.org/wgbh/nova/heart/pioneers.html" class="external text" title="http://www.pbs.org/wgbh/nova/heart/pioneers.html" rel="nofollow">"Pioneers of heart surgery"</a>. <i>NOVA Online: Cut to the heart</i><span class="printonly">. <a href="http://www.pbs.org/wgbh/nova/heart/pioneers.html" class="external free" title="http://www.pbs.org/wgbh/nova/heart/pioneers.html" rel="nofollow">http://www.pbs.org/wgbh/nova/heart/pioneers.html</a></span><span class="reference-accessdate">. Retrieved on 2007-11-07</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Pioneers+of+heart+surgery&amp;rft.atitle=NOVA+Online%3A+Cut+to+the+heart&amp;rft_id=http%3A%2F%2Fwww.pbs.org%2Fwgbh%2Fnova%2Fheart%2Fpioneers.html&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11326231-59"><b><a href="#cite_ref-pmid11326231_59-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFranco-Cereceda_A.2C_McCarthy_PM.2C_Blackstone_EH.2C_.27.27et_al.27.272001">Franco-Cereceda A, McCarthy PM, Blackstone EH, <i>et al</i> (May 2001). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)37736-X" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)37736-X" rel="nofollow">Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation?</a>". <i>J. Thorac. Cardiovasc. Surg.</i> <b>121</b> (5): 879–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1067%2Fmtc.2001.113598" class="external text" title="http://dx.doi.org/10.1067%2Fmtc.2001.113598" rel="nofollow">10.1067/mtc.2001.113598</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11326231" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11326231">PMID 11326231</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)37736-X" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)37736-X" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(01)37736-X</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Partial+left+ventriculectomy+for+dilated+cardiomyopathy%3A+is+this+an+alternative+to+transplantation%3F&amp;rft.jtitle=J.+Thorac.+Cardiovasc.+Surg.&amp;rft.aulast=Franco-Cereceda+A%2C+McCarthy+PM%2C+Blackstone+EH%2C+%27%27et+al%27%27&amp;rft.au=Franco-Cereceda+A%2C+McCarthy+PM%2C+Blackstone+EH%2C+%27%27et+al%27%27&amp;rft.date=May+2001&amp;rft.volume=121&amp;rft.issue=5&amp;rft.pages=879%E2%80%9393&amp;rft_id=info:doi/10.1067%2Fmtc.2001.113598&amp;rft_id=info:pmid/11326231&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0022-5223%2801%2937736-X&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14566236-60"><b><a href="#cite_ref-pmid14566236_60-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOz_MC.2C_Konertz_WF.2C_Kleber_FX.2C_.27.27et_al.27.272003">Oz MC, Konertz WF, Kleber FX, <i>et al</i> (October 2003). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0022522303000497" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0022522303000497" rel="nofollow">Global surgical experience with the Acorn cardiac support device</a>". <i>J. Thorac. Cardiovasc. Surg.</i> <b>126</b> (4): 983–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0022-5223%2803%2900049-7" class="external text" title="http://dx.doi.org/10.1016%2FS0022-5223%2803%2900049-7" rel="nofollow">10.1016/S0022-5223(03)00049-7</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14566236" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14566236">PMID 14566236</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022522303000497" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0022522303000497" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0022522303000497</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Global+surgical+experience+with+the+Acorn+cardiac+support+device&amp;rft.jtitle=J.+Thorac.+Cardiovasc.+Surg.&amp;rft.aulast=Oz+MC%2C+Konertz+WF%2C+Kleber+FX%2C+%27%27et+al%27%27&amp;rft.au=Oz+MC%2C+Konertz+WF%2C+Kleber+FX%2C+%27%27et+al%27%27&amp;rft.date=October+2003&amp;rft.volume=126&amp;rft.issue=4&amp;rft.pages=983%E2%80%9391&amp;rft_id=info:doi/10.1016%2FS0022-5223%2803%2900049-7&amp;rft_id=info:pmid/14566236&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0022522303000497&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12057702-61"><b><a href="#cite_ref-pmid12057702_61-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchenk_S.2C_Reichenspurner_H.2C_Boehm_DH.2C_.27.27et_al.27.272002">Schenk S, Reichenspurner H, Boehm DH, <i>et al</i> (June 2002). "Myosplint implant and shape-change procedure: intra- and peri-operative safety and feasibility". <i>J. Heart Lung Transplant.</i> <b>21</b> (6): 680–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1053-2498%2801%2900773-2" class="external text" title="http://dx.doi.org/10.1016%2FS1053-2498%2801%2900773-2" rel="nofollow">10.1016/S1053-2498(01)00773-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12057702" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12057702">PMID 12057702</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Myosplint+implant+and+shape-change+procedure%3A+intra-+and+peri-operative+safety+and+feasibility&amp;rft.jtitle=J.+Heart+Lung+Transplant.&amp;rft.aulast=Schenk+S%2C+Reichenspurner+H%2C+Boehm+DH%2C+%27%27et+al%27%27&amp;rft.au=Schenk+S%2C+Reichenspurner+H%2C+Boehm+DH%2C+%27%27et+al%27%27&amp;rft.date=June+2002&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=680%E2%80%936&amp;rft_id=info:doi/10.1016%2FS1053-2498%2801%2900773-2&amp;rft_id=info:pmid/12057702&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17449141-62"><b><a href="#cite_ref-pmid17449141_62-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAuble_TE.2C_Hsieh_M.2C_McCausland_JB.2C_Yealy_DM2007">Auble TE, Hsieh M, McCausland JB, Yealy DM (2007). "Comparison of four clinical prediction rules for estimating risk in heart failure". <i>Annals of emergency medicine</i> <b>50</b> (2): 127–35, 135.e1–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.annemergmed.2007.02.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.annemergmed.2007.02.017" rel="nofollow">10.1016/j.annemergmed.2007.02.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17449141" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17449141">PMID 17449141</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Comparison+of+four+clinical+prediction+rules+for+estimating+risk+in+heart+failure&amp;rft.jtitle=Annals+of+emergency+medicine&amp;rft.aulast=Auble+TE%2C+Hsieh+M%2C+McCausland+JB%2C+Yealy+DM&amp;rft.au=Auble+TE%2C+Hsieh+M%2C+McCausland+JB%2C+Yealy+DM&amp;rft.date=2007&amp;rft.volume=50&amp;rft.issue=2&amp;rft.pages=127%E2%80%9335%2C+135.e1%E2%80%932&amp;rft_id=info:doi/10.1016%2Fj.annemergmed.2007.02.017&amp;rft_id=info:pmid/17449141&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-63"><b><a href="#cite_ref-63" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKrumholz_HM.2C_Chen_YT.2C_Wang_Y.2C_Vaccarino_V.2C_Radford_MJ.2C_Horwitz_RI2000">Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI (2000). "Predictors of readmission among elderly survivors of admission with heart failure". <i>Am. Heart J.</i> <b>139</b> (1 Pt 1): 72–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0002-8703%2800%2990311-9" class="external text" title="http://dx.doi.org/10.1016%2FS0002-8703%2800%2990311-9" rel="nofollow">10.1016/S0002-8703(00)90311-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10618565" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10618565">PMID 10618565</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Predictors+of+readmission+among+elderly+survivors+of+admission+with+heart+failure&amp;rft.jtitle=Am.+Heart+J.&amp;rft.aulast=Krumholz+HM%2C+Chen+YT%2C+Wang+Y%2C+Vaccarino+V%2C+Radford+MJ%2C+Horwitz+RI&amp;rft.au=Krumholz+HM%2C+Chen+YT%2C+Wang+Y%2C+Vaccarino+V%2C+Radford+MJ%2C+Horwitz+RI&amp;rft.date=2000&amp;rft.volume=139&amp;rft.issue=1+Pt+1&amp;rft.pages=72%E2%80%937&amp;rft_id=info:doi/10.1016%2FS0002-8703%2800%2990311-9&amp;rft_id=info:pmid/10618565&amp;rfr_id=info:sid/en.wikipedia.org:Heart_failure"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Heart_failure&amp;action=edit&amp;section=45" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.americanheart.org/heartfailure" class="external text" title="http://www.americanheart.org/heartfailure" rel="nofollow">American Heart Association's Heart Failure web site</a> - information and resources for treating and living with heart failure.</li>
<li><a href="http://www.heartfailurematters.org" class="external text" title="http://www.heartfailurematters.org" rel="nofollow">Heart Failure Matters</a> – patient information website of the Heart Failure Association of the European Society of Cardiology</li>
<li><a href="http://heartcenter.seattlechildrens.org/conditions_treated/congestive_heart_failure.asp" class="external text" title="http://heartcenter.seattlechildrens.org/conditions_treated/congestive_heart_failure.asp" rel="nofollow">Congestive Heart Failure information</a> from Seattle Children's Hospital Heart Center</li>
<li><a href="http://www.heartfailure-europe.com" class="external text" title="http://www.heartfailure-europe.com" rel="nofollow">www.heartfailure-europe.com</a> – patient information website of SHAPE (Study Group on Heart failure Awareness and Perception in Europe)</li>
<li><a href="http://www.thacinc.com" class="external text" title="http://www.thacinc.com" rel="nofollow">the Healthcare Accreditation Colloquium's web site</a> - The Four Domains of Heart Failure and Accreditation of Heart Failure Institutes.</li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Heart_diseases" title="Template:Heart diseases"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Heart_diseases" title="Template talk:Heart diseases"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Heart_diseases&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Heart_diseases&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">Cardiovascular disease</a>: <a href="/wiki/Heart_disease" title="Heart disease">heart disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Circulatory_system" title="Circulatory system">Circulatory system</a> <a href="/wiki/Pathology" title="Pathology">pathology</a> (<a href="/wiki/ICD-10_Chapter_IX:_Diseases_of_the_circulatory_system" title="ICD-10 Chapter IX: Diseases of the circulatory system">I00-I52</a>, <a href="/wiki/List_of_ICD-9_codes_390-459:_Diseases_of_the_circulatory_system" title="List of ICD-9 codes 390-459: Diseases of the circulatory system" class="mw-redirect">390-429</a>)</span></th>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Ischaemic_heart_disease" title="Ischaemic heart disease">Ischaemic</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Coronary_disease" title="Coronary disease">CD/CHD</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">CAD</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coronary_thrombosis" title="Coronary thrombosis">Coronary thrombosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coronary_vasospasm" title="Coronary vasospasm">Coronary vasospasm</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coronary_artery_aneurysm" title="Coronary artery aneurysm">Coronary artery aneurysm</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Active <a href="/wiki/Ischemia" title="Ischemia">ischemia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Angina_pectoris" title="Angina pectoris">Angina pectoris</a> (<a href="/wiki/Prinzmetal%27s_angina" title="Prinzmetal's angina">Prinzmetal's angina</a>, <a href="/wiki/Stable_angina" title="Stable angina" class="mw-redirect">Stable angina</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acute_coronary_syndrome" title="Acute coronary syndrome">Acute coronary</a> (<a href="/wiki/Unstable_angina" title="Unstable angina">Unstable angina</a>, <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">Myocardial infarction / heart attack</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Myocardial_infarction#Complications" title="Myocardial infarction">Sequelae</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>hours</i> (<a href="/wiki/Myocardial_stunning" title="Myocardial stunning">Myocardial stunning</a>, <a href="/wiki/Hibernating_myocardium" title="Hibernating myocardium">Hibernating myocardium</a>)<span style="font-weight:bold;">&#160;·</span> <i>days</i> (<a href="/wiki/Myocardial_rupture" title="Myocardial rupture">Myocardial rupture</a>)<span style="font-weight:bold;">&#160;·</span> <i>weeks</i> (<a href="/wiki/Aneurysm_of_heart" title="Aneurysm of heart">Aneurysm of heart</a>, <a href="/wiki/Dressler%27s_syndrome" title="Dressler's syndrome">Dressler's syndrome</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;">Layers</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pericardium" title="Pericardium">Pericardium</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pericarditis" title="Pericarditis">Pericarditis</a> (<a href="/wiki/Acute_pericarditis" title="Acute pericarditis">Acute</a>, <a href="/wiki/Pericarditis#Acute_vs._chronic" title="Pericarditis">Chronic</a>/<a href="/wiki/Constrictive_pericarditis" title="Constrictive pericarditis">Constrictive</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pericardial_effusion" title="Pericardial effusion">Pericardial effusion</a> (<a href="/wiki/Hemopericardium" title="Hemopericardium">Hemopericardium</a>, <a href="/wiki/Cardiac_tamponade" title="Cardiac tamponade">Cardiac tamponade</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Myocardium" title="Myocardium" class="mw-redirect">Myocardium</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Myocarditis" title="Myocarditis">Myocarditis</a> (<a href="/wiki/Chagas_disease" title="Chagas disease">Chagas disease</a>)
<p><a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">Cardiomyopathy</a>: <a href="/wiki/Dilated_cardiomyopathy" title="Dilated cardiomyopathy">Dilated</a> (<a href="/wiki/Alcoholic_cardiomyopathy" title="Alcoholic cardiomyopathy">Alcoholic</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypertrophic_cardiomyopathy" title="Hypertrophic cardiomyopathy">Hypertrophic</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Restrictive_cardiomyopathy" title="Restrictive cardiomyopathy">Restrictive</a> (<a href="/wiki/Loeffler_endocarditis" title="Loeffler endocarditis">Loeffler endocarditis</a>, <a href="/wiki/Cardiac_amyloidosis" title="Cardiac amyloidosis">Cardiac amyloidosis</a>, <a href="/wiki/Endocardial_fibroelastosis" title="Endocardial fibroelastosis">Endocardial fibroelastosis</a>)</p>
<a href="/wiki/Arrhythmogenic_right_ventricular_dysplasia" title="Arrhythmogenic right ventricular dysplasia">Arrhythmogenic right ventricular dysplasia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Endocardium" title="Endocardium">Endocardium</a>/<br />
<a href="/wiki/Valvular_heart_disease" title="Valvular heart disease">valves</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Endocarditis" title="Endocarditis">Endocarditis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Infective_endocarditis" title="Infective endocarditis">Infective endocarditis</a> (<a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a>)<span style="font-weight:bold;">&#160;·</span> <i>noninfective endocarditis</i> (<a href="/wiki/Nonbacterial_thrombotic_endocarditis" title="Nonbacterial thrombotic endocarditis">Nonbacterial thrombotic endocarditis</a>, <a href="/wiki/Libman-Sacks_endocarditis" title="Libman-Sacks endocarditis">Libman-Sacks endocarditis</a>)<br /></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Valves</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Mitral_valve" title="Mitral valve">mitral</a></i> (<a href="/wiki/Mitral_regurgitation" title="Mitral regurgitation">regurgitation</a>, <a href="/wiki/Mitral_valve_prolapse" title="Mitral valve prolapse">prolapse</a>, <a href="/wiki/Mitral_stenosis" title="Mitral stenosis">stenosis</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Aortic_valve" title="Aortic valve">aortic</a></i> (<a href="/wiki/Aortic_valve_stenosis" title="Aortic valve stenosis">stenosis</a>, <a href="/wiki/Aortic_insufficiency" title="Aortic insufficiency">insufficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Tricuspid_valve" title="Tricuspid valve">tricuspid</a></i> (<a href="/wiki/Tricuspid_valve_stenosis" title="Tricuspid valve stenosis">stenosis</a>, <a href="/wiki/Tricuspid_insufficiency" title="Tricuspid insufficiency">insufficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Pulmonary_valve" title="Pulmonary valve">pulmonary</a></i> (<a href="/wiki/Pulmonary_valve_stenosis" title="Pulmonary valve stenosis">stenosis</a>, <a href="/wiki/Pulmonary_valve_insufficiency" title="Pulmonary valve insufficiency">insufficiency</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Electrical_conduction_system_of_the_heart" title="Electrical conduction system of the heart">Conduction</a>/<br />
<a href="/wiki/Cardiac_arrhythmia" title="Cardiac arrhythmia">arrhythmia</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Bradycardia" title="Bradycardia">Bradycardia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Sinus_bradycardia" title="Sinus bradycardia">Sinus bradycardia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sick_sinus_syndrome" title="Sick sinus syndrome">Sick sinus syndrome</a><br />
<a href="/wiki/Heart_block" title="Heart block">Heart block</a>: <a href="/wiki/Sinoatrial_block" title="Sinoatrial block">Sinoatrial</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Atrioventricular_block" title="Atrioventricular block">AV</a> (<a href="/wiki/First_degree_AV_block" title="First degree AV block" class="mw-redirect">1°</a>, <a href="/wiki/Second_degree_AV_block" title="Second degree AV block" class="mw-redirect">2°</a>, <a href="/wiki/Third_degree_AV_block" title="Third degree AV block" class="mw-redirect">3°</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Intraventricular_block" title="Intraventricular block">Intraventricular</a> (<a href="/wiki/Bundle_branch_block" title="Bundle branch block">Bundle branch</a>/<a href="/wiki/Right_bundle_branch_block" title="Right bundle branch block">Right</a>/<a href="/wiki/Left_bundle_branch_block" title="Left bundle branch block">Left</a>, <a href="/wiki/Left_anterior_fascicular_block" title="Left anterior fascicular block">Left anterior fascicular</a>/<a href="/wiki/Left_posterior_fascicular_block" title="Left posterior fascicular block">Left posterior fascicular</a>, <a href="/wiki/Bifascicular_block" title="Bifascicular block">Bifascicular</a>/<a href="/wiki/Trifascicular_block" title="Trifascicular block">Trifascicular</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adams-Stokes_syndrome" title="Adams-Stokes syndrome">Adams-Stokes syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Tachycardia" title="Tachycardia">Tachycardia</a><br />
(<a href="/wiki/Paroxysmal_tachycardia" title="Paroxysmal tachycardia">paroxysmal</a> and <a href="/wiki/Sinus_tachycardia" title="Sinus tachycardia">sinus</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Supraventricular_tachycardia" title="Supraventricular tachycardia">Supraventricular</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atrial_tachycardia" title="Atrial tachycardia">Atrial</a> (<a href="/wiki/Multifocal_atrial_tachycardia" title="Multifocal atrial tachycardia">Multifocal</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Junctional_tachycardia" title="Junctional tachycardia">Junctional</a> (<a href="/wiki/AV_nodal_reentrant_tachycardia" title="AV nodal reentrant tachycardia">AV nodal reentrant</a>, <a href="/wiki/Junctional_ectopic_tachycardia" title="Junctional ectopic tachycardia">Junctional ectopic</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Ventricular_tachycardia" title="Ventricular tachycardia">Ventricular</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Torsades_de_pointes" title="Torsades de pointes">Torsades de pointes</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Catecholaminergic_polymorphic_ventricular_tachycardia" title="Catecholaminergic polymorphic ventricular tachycardia">Catecholaminergic polymorphic</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Accelerated_idioventricular_rhythm" title="Accelerated idioventricular rhythm">Accelerated idioventricular rhythm</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Premature contraction</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Premature_atrial_contraction" title="Premature atrial contraction">Atrial</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Premature_ventricular_contraction" title="Premature ventricular contraction">Ventricular</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pre-excitation_syndrome" title="Pre-excitation syndrome">Pre-excitation syndrome</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Wolff-Parkinson-White_syndrome" title="Wolff-Parkinson-White syndrome">Wolff-Parkinson-White</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Lown-Ganong-Levine_syndrome" title="Lown-Ganong-Levine syndrome">Lown-Ganong-Levine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Flutter/<a href="/wiki/Fibrillation" title="Fibrillation">fibrillation</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atrial_flutter" title="Atrial flutter">Atrial flutter</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ventricular_flutter" title="Ventricular flutter">Ventricular flutter</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">Atrial fibrillation</a> (<a href="/wiki/Familial_atrial_fibrillation" title="Familial atrial fibrillation">Familial</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ventricular_fibrillation" title="Ventricular fibrillation">Ventricular fibrillation</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pacemaker" title="Pacemaker" class="mw-redirect">Pacemaker</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Wandering_pacemaker" title="Wandering pacemaker">Wandering pacemaker</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ectopic_pacemaker" title="Ectopic pacemaker">Ectopic pacemaker</a>/<a href="/wiki/Ectopic_beat" title="Ectopic beat">Ectopic beat</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Parasystole" title="Parasystole">Parasystole</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multifocal_atrial_tachycardia" title="Multifocal atrial tachycardia">Multifocal atrial tachycardia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pacemaker_syndrome" title="Pacemaker syndrome">Pacemaker syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Romano-Ward_syndrome" title="Romano-Ward syndrome">Romano-Ward syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Andersen-Tawil_syndrome" title="Andersen-Tawil syndrome">Andersen-Tawil syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Jervell_and_Lange-Nielsen_syndrome" title="Jervell and Lange-Nielsen syndrome">Jervell and Lange-Nielsen syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cardiac_arrest" title="Cardiac arrest">Cardiac arrest</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Sudden_cardiac_death" title="Sudden cardiac death">Sudden cardiac death</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Asystole" title="Asystole">Asystole</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pulseless_electrical_activity" title="Pulseless electrical activity">Pulseless electrical activity</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Other/ungrouped</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Right_axis_deviation" title="Right axis deviation">Right axis deviation</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Short_QT_syndrome" title="Short QT syndrome">Short QT syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sinoatrial_arrest" title="Sinoatrial arrest">Sinoatrial arrest</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/T_wave_alternans" title="T wave alternans">T wave alternans</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cardiac_fibrosis" title="Cardiac fibrosis">Cardiac fibrosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cardiomegaly" title="Cardiomegaly">Cardiomegaly</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ventricular_hypertrophy" title="Ventricular hypertrophy">Ventricular hypertrophy</a> (<a href="/wiki/Left_ventricular_hypertrophy" title="Left ventricular hypertrophy">Left</a>, <a href="/wiki/Right_ventricular_hypertrophy" title="Right ventricular hypertrophy">Right</a>/<a href="/wiki/Cor_pulmonale" title="Cor pulmonale">Cor pulmonale</a>)<br />
<strong class="selflink">Heart failure</strong> (<a href="/wiki/Cardiac_asthma" title="Cardiac asthma">Cardiac asthma</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>See also <a href="/wiki/Template:Congenital_malformations_and_deformations_of_circulatory_system" title="Template:Congenital malformations and deformations of circulatory system" class="mw-redirect">congenital</a>, <a href="/wiki/Template:Heart_and_thymus_neoplasia" title="Template:Heart and thymus neoplasia">neoplasia</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Organ_failure" title="Template:Organ failure"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Organ_failure&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Organ failure (page does not exist)"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Organ_failure&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Organ_failure&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Organ_failure" title="Organ failure">Organ failure</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">General</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><strong class="selflink">Heart failure</strong><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Respiratory_failure" title="Respiratory failure">Respiratory failure</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Liver_failure" title="Liver failure">Liver failure</a> (<a href="/wiki/Acute_liver_failure" title="Acute liver failure">Acute liver failure</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Renal_failure" title="Renal failure">Renal failure</a> (<a href="/wiki/Acute_renal_failure" title="Acute renal failure">Acute renal failure</a>, <a href="/wiki/Chronic_renal_failure" title="Chronic renal failure" class="mw-redirect">Chronic renal failure</a> )</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Multiple</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Multiple_organ_dysfunction_syndrome" title="Multiple organ dysfunction syndrome">Multiple organ dysfunction syndrome</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 31513/1000000
Post-expand include size: 427346/2048000 bytes
Template argument size: 191410/2048000 bytes
Expensive parser function count: 3/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:249930-0!1!0!default!!en!2 and timestamp 20090404182005 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Heart_failure">http://en.wikipedia.org/wiki/Heart_failure</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Aging-associated_diseases" title="Category:Aging-associated diseases">Aging-associated diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Cardiology" title="Category:Cardiology">Cardiology</a></span> | <span dir='ltr'><a href="/wiki/Category:Cardiovascular_diseases" title="Category:Cardiovascular diseases">Cardiovascular diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Causes_of_death" title="Category:Causes of death">Causes of death</a></span> | <span dir='ltr'><a href="/wiki/Category:Organ_failure" title="Category:Organ failure">Organ failure</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_dead_external_links_since_June_2008" title="Category:Articles with dead external links since June 2008">Articles with dead external links since June 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_July_2008" title="Category:Articles with unsourced statements since July 2008">Articles with unsourced statements since July 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_needing_additional_references_from_December_2007" title="Category:Articles needing additional references from December 2007">Articles needing additional references from December 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Wikipedia_articles_to_be_split_from_December_2008" title="Category:Wikipedia articles to be split from December 2008">Wikipedia articles to be split from December 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_to_be_expanded_since_November_2008" title="Category:Articles to be expanded since November 2008">Articles to be expanded since November 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_to_be_expanded" title="Category:All articles to be expanded">All articles to be expanded</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Heart_failure" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Heart_failure" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Heart_failure&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Heart_failure&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Heart_failure" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Heart_failure" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Heart_failure" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Heart_failure&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Heart_failure&amp;oldid=281740925" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Heart_failure&amp;id=281740925">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D9%82%D8%B5%D9%88%D8%B1_%D8%A7%D9%84%D9%82%D9%84%D8%A8">العربية</a></li>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%A1%D1%8A%D1%80%D0%B4%D0%B5%D1%87%D0%BD%D0%B0_%D0%BD%D0%B5%D0%B4%D0%BE%D1%81%D1%82%D0%B0%D1%82%D1%8A%D1%87%D0%BD%D0%BE%D1%81%D1%82">Български</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Herzinsuffizienz">Deutsch</a></li>
				<li class="interwiki-dv"><a href="http://dv.wikipedia.org/wiki/%DE%80%DE%A8%DE%8C%DE%B0_%DE%8A%DE%AD%DE%8D%DE%B0%DE%88%DE%AA%DE%82%DE%B0">ދިވެހިބަސް</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Insuficiencia_card%C3%ADaca">Español</a></li>
				<li class="interwiki-eu"><a href="http://eu.wikipedia.org/wiki/Bihotz-gutxiegitasun">Euskara</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Insuffisance_cardiaque">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Insufficienza_cardiaca">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%90%D7%99_%D7%A1%D7%A4%D7%99%D7%A7%D7%AA_%D7%9C%D7%91">עברית</a></li>
				<li class="interwiki-pam"><a href="http://pam.wikipedia.org/wiki/Pamagpalya_ning_pusu">Kapampangan</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Hartfalen">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E5%BF%83%E4%B8%8D%E5%85%A8">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Hjertesvikt">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-nn"><a href="http://nn.wikipedia.org/wiki/Hjartesvikt">‪Norsk (nynorsk)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Niewydolno%C5%9B%C4%87_serca">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Insufici%C3%AAncia_card%C3%ADaca">Português</a></li>
				<li class="interwiki-ro"><a href="http://ro.wikipedia.org/wiki/Insuficien%C5%A3a_cardiac%C4%83">Română</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%A1%D0%B5%D1%80%D0%B4%D0%B5%D1%87%D0%BD%D0%B0%D1%8F_%D0%BD%D0%B5%D0%B4%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%BE%D1%87%D0%BD%D0%BE%D1%81%D1%82%D1%8C">Русский</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Heart_failure">Simple English</a></li>
				<li class="interwiki-sl"><a href="http://sl.wikipedia.org/wiki/Sr%C4%8Dna_insuficienca">Slovenščina</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Syd%C3%A4men_vajaatoiminta">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Hj%C3%A4rtsvikt">Svenska</a></li>
				<li class="interwiki-th"><a href="http://th.wikipedia.org/wiki/%E0%B8%A0%E0%B8%B2%E0%B8%A7%E0%B8%B0%E0%B8%AB%E0%B8%B1%E0%B8%A7%E0%B9%83%E0%B8%88%E0%B8%A7%E0%B8%B2%E0%B8%A2">ไทย</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Kalp_yetmezli%C4%9Fi">Türkçe</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%A1%D0%B5%D1%80%D1%86%D0%B5%D0%B2%D0%B0_%D0%BD%D0%B5%D0%B4%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%BD%D1%96%D1%81%D1%82%D1%8C">Українська</a></li>
				<li class="interwiki-ur"><a href="http://ur.wikipedia.org/wiki/%D8%B9%D9%8E%D8%AC%D8%B2%D9%90_%D9%82%D9%84%D8%A8">اردو</a></li>
				<li class="interwiki-vi"><a href="http://vi.wikipedia.org/wiki/Suy_tim_%E1%BB%A9_huy%E1%BA%BFt">Tiếng Việt</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E5%BF%83%E8%A1%B0%E7%AB%AD">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 4 April 2009, at 18:20.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv103 in 0.082 secs. --></body></html>
